Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",3.5957359778798284e-13,3.359802529910705,96.27130297417757,"['NPFFR2', 'GPR27', 'OXTR', 'NPFFR1', 'CHRM1', 'GPR68', 'GPR65', 'GPR22', 'HTR2B', 'GPR20', 'ADRA1D', 'MC4R', 'CYSLTR1', 'HTR7', 'CYSLTR2', 'ADORA3', 'GPR171', 'C3AR1', 'CMKLR1', 'PTGDR', 'GPR39', 'PTGIR', 'GPR34', 'OR2H2', 'GPR37L1', 'SSTR1', 'SSTR3', 'TRHR', 'CCKBR', 'ADORA2A', 'ADORA2B', 'FSHR', 'OR7A5', 'OR3A2', 'CX3CR1', 'GPR87', 'PTAFR', 'CXCR5', 'OPRL1', 'CXCR4', 'GPR83', 'ADRB1', 'ADRB2', 'MCHR1', 'P2RY6', 'CNR2', 'OR2AG1', 'P2RY1', 'RHO', 'DRD3', 'NTSR1', 'DRD5', 'CCR1', 'GPR17', 'GPR12', 'HTR1E', 'P2RY14', 'HTR1D', 'GPR52', 'GPR4', 'GPR3', 'GPR6', 'HTR5A', 'HCRTR2', 'HCRTR1', 'MAS1', 'OPN1SW', 'LPAR5', 'ACKR4', 'ACKR2', 'RGL4', 'OR7C1', 'GPR18', 'F2RL2']",2.1071012830375795e-10,0,0,74
2,TYROBP causal network in microglia WP3945,8.76695820112519e-12,6.420206659012629,163.45866192007514,"['CD84', 'RBM47', 'ITGAM', 'PLEK', 'ITGB2', 'GIMAP2', 'CAPG', 'TCIRG1', 'SLC1A5', 'SAMSN1', 'ZFP36L2', 'CXCL16', 'C3', 'LYL1', 'ADAP2', 'CREB3L2', 'ITGAX', 'SPP1', 'CD37', 'CYTL1', 'NCKAP1L', 'GAL3ST4', 'IL13RA1', 'STAT5A', 'IL10RA', 'RNASE6', 'LHFPL2', 'TNFRSF1B', 'RUNX3', 'APBB1IP', 'TYROBP', 'BIN2', 'ELF4', 'HCLS1', 'TMEM106A', 'C1QC']",2.5687187529296804e-09,0,0,36
3,Complement system WP2806,1.4623012123895977e-07,3.384932031399579,53.27234560315542,"['FCN1', 'FKBP2', 'SELPLG', 'CFH', 'SFTPA2', 'C1R', 'CFI', 'C5AR1', 'ITGB2', 'ICAM2', 'F13A1', 'C4BPA', 'PLG', 'LRP2', 'THBS1', 'C3', 'FCGR3A', 'C6', 'C7', 'C9', 'C3AR1', 'ITGAX', 'SPP1', 'VSIG4', 'ELANE', 'PRNP', 'CR1', 'CD93', 'ITGA2', 'F12', 'F11', 'APOA1', 'SELE', 'SELP', 'ALB', 'MASP2', 'PTX3', 'TLR2']",2.8563617015343475e-05,0,0,38
4,Microglia Pathogen Phagocytosis Pathway WP3937,3.1728257665675586e-07,5.365652702316271,80.28879961281277,"['C1QB', 'VAV3', 'LYN', 'C1QA', 'ITGAM', 'FCER1G', 'NCF1', 'SYK', 'NCF4', 'ITGB2', 'CYBB', 'TREM2', 'CYBA', 'PIK3R6', 'VAV1', 'HCK', 'TYROBP', 'PLCG2', 'NCKAP1L', 'PTPN6', 'FCGR1A', 'SIGLEC7', 'C1QC']",4.6481897480214736e-05,0,0,23
5,Spinal Cord Injury WP2431,9.272995570194639e-06,2.4930036419398123,28.88993358532409,"['C1QB', 'CDKN1B', 'XYLT1', 'AQP4', 'CXCL1', 'PLA2G5', 'AIF1', 'RTN4', 'EGFR', 'AQP1', 'TNFSF13B', 'LGALS3', 'ACAN', 'GJA1', 'ZFP36', 'CHST11', 'PRB1', 'PTPRZ1', 'SOX9', 'ROS1', 'MAPK3', 'NGFR', 'EGR1', 'IL1R1', 'TNFSF13', 'MIF', 'LILRB2', 'PDYN', 'RHOC', 'GFAP', 'SELP', 'FKBP1A', 'NR4A1', 'VCAN', 'FCGR2A', 'LEP', 'APEX1', 'CDK2', 'CSPG4', 'LTB', 'VIM', 'TLR4']",0.0010867950808268116,0,0,42
6,Hematopoietic Stem Cell Differentiation WP2849,2.2664020677327175e-05,3.574909446191974,38.23269803336364,"['STAT5A', 'NOTCH1', 'CSF1', 'LEF1', 'RHOH', 'CXCR4', 'NFATC2', 'IKZF1', 'GATA2', 'GATA1', 'VAV1', 'ABO', 'FLI1', 'RUNX1', 'LYL1', 'MUC1', 'TPO', 'IL5', 'TRIM29', 'PIM1', 'FOSB', 'NCKAP1L', 'CD34']",0.0022135193528189543,0,0,23
7,Vitamin D Receptor Pathway WP2877,2.7676678992588477e-05,2.1501209049653847,22.565347775948428,"['STEAP4', 'ITGAM', 'CDKN1B', 'TNFAIP3', 'CLDN2', 'THBD', 'SULT1C2', 'CASP5', 'DACT2', 'TIMP2', 'SOSTDC1', 'CA9', 'LGALS9', 'JUNB', 'EPHB4', 'IGFBP5', 'CEACAM1', 'S100A6', 'IRF8', 'S100A4', 'S100A9', 'S100A8', 'COLEC11', 'CEBPA', 'COL13A1', 'LRP5', 'TNFRSF11B', 'ADRB2', 'CYP3A4', 'CYP3A5', 'FOXO1', 'IL1RL1', 'CLMN', 'ALOX5', 'CREG2', 'BTLA', 'SPP1', 'CD14', 'CDKN2D', 'LRRC25', 'VDR', 'CDKN2A', 'MX2', 'NFATC2', 'KLF4', 'TRPV6', 'BCL6', 'CDK2', 'PNOC', 'HLA-DRB1']",0.0023169334128081208,0,0,50
8,Complement and Coagulation Cascades WP558,5.114359622744503e-05,3.1973684210526314,31.592792163838553,"['C1QB', 'C1QA', 'SERPINA1', 'CR1', 'VWF', 'CFH', 'SERPIND1', 'C1R', 'F12', 'SERPINF2', 'C5AR1', 'CFI', 'PLG', 'TFPI', 'F5', 'C3', 'THBD', 'F7', 'C6', 'C7', 'C9', 'C3AR1', 'MASP2', 'C1QC']",0.003746268423660348,0,0,24
9,White fat cell differentiation WP4149,6.342495466544618e-05,4.585879873551106,44.32552432443281,"['STAT5A', 'CEBPA', 'CEBPB', 'TCF7L1', 'EGR2', 'CEBPD', 'EBF1', 'RORA', 'NR2F2', 'GATA2', 'KLF4', 'KLF15', 'FOXO1', 'MECOM', 'DDIT3', 'ZNF423']",0.004129669270439051,0,0,16
10,"GPCRs, Other WP117",8.179307626475938e-05,2.7496533429794416,25.877861891045995,"['GPR88', 'ADRA1D', 'GPR83', 'ADRB2', 'GPR84', 'ADGRE2', 'GPR132', 'PROKR2', 'HTR7', 'ADORA3', 'ADGRE3', 'HRH4', 'GNRHR', 'S1PR1', 'DRD3', 'NTSR1', 'GPR17', 'ADGRV1', 'GPR55', 'GPR162', 'GPR143', 'CCKBR', 'SMO', 'ADORA2A', 'FSHR', 'OR10A2', 'LGR6', 'GPR18']",0.0047930742691149,0,0,28
11,Proximal tubule transport WP4917,0.0003472746115769222,2.828019952288007,22.526295148413688,"['ATP6V1A', 'SLC47A2', 'ATP6V1G1', 'SLC22A6', 'SLC12A4', 'ABCC2', 'SLC3A1', 'ATP1A1', 'ATP1B1', 'SLC5A2', 'SLC4A4', 'AQP1', 'FXYD2', 'ATP6V0A4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0D2', 'ATP6V0C', 'ATP6V1D', 'ABCG2', 'ATP6V1B1', 'ATP6V1F']",0.018500265671279673,0,0,22
12,Dopaminergic Neurogenesis WP2855,0.00040968646052642687,6.202754036087369,48.382216019335246,"['NEUROD1', 'SOX2', 'FGF8', 'ALDH1A1', 'MSX1', 'GLI1', 'ASCL1', 'SLC18A2', 'GLI2', 'NKX2-2']",0.020006355489040513,0,0,10
13,Macrophage markers WP4146,0.00046086303045725726,13.018645032735554,100.01456453001671,"['CD86', 'CD74', 'CD163', 'CD83', 'CD14', 'LYZ', 'CD68']",0.020774287372919444,0,0,7
14,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.0005195794901645194,1.8884017536867277,14.281020787555482,"['TPH1', 'DLX2', 'CEBPB', 'YWHAB', 'CDCA7L', 'SLC1A3', 'ATP1A3', 'AQP4', 'RORA', 'GATA2', 'FOXM1', 'ASCL1', 'SOX2', 'NEUROD1', 'GJA1', 'HES1', 'PKNOX1', 'SCN3B', 'TAC1', 'YWHAG', 'HES5', 'NKX2-2', 'YWHAH', 'NKX3-1', 'CHRNB2', 'EGR1', 'GABRA1', 'CPT1A', 'JUN', 'TSPYL1', 'CAV3', 'SSTR1', 'RUNX3', 'GCK', 'VEGFA', 'ADCYAP1', 'TF', 'PRKAR1A', 'SST', 'PAH', 'BHLHE40', 'CHRFAM7A', 'ALDOA', 'GAPDH', 'SCN4B', 'SLC25A4']",0.021748112945457736,0,0,46
15,Heart Development WP1591,0.0007022130560912669,3.4913516405135523,25.351659849179644,"['TBX1', 'FOXC1', 'NOTCH1', 'VEGFC', 'NFATC2', 'NFATC1', 'VEGFA', 'TBX2', 'FGF8', 'HEY1', 'ERBB3', 'HEY2', 'BHLHE40', 'SMYD1', 'FGF10']",0.027433123391298827,0,0,15
16,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.0008058751759774727,5.316239316239316,37.87066508453355,"['TLR1', 'JUN', 'TIFA', 'TLR9', 'TLR7', 'TLR10', 'TLR6', 'TLR5', 'TLR4', 'TLR2']",0.029515178320174938,0,0,10
17,Glycolysis and Gluconeogenesis WP534,0.0009145024593317918,2.915452039828173,20.399798100169257,"['TPI1', 'PKLR', 'GOT1', 'MDH2', 'PGAM1', 'SLC2A3', 'ENO2', 'SLC2A5', 'HK2', 'GCK', 'LDHC', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH']",0.03137985737731841,0,0,18
18,Allograft Rejection WP2328,0.0009638864040814528,2.4179602943905003,16.79161499100109,"['CD86', 'C1QB', 'PDGFRA', 'C1QA', 'HLA-DRB5', 'CD80', 'CXCR5', 'CXCL13', 'HLA-E', 'VEGFA', 'C3', 'CASP7', 'C6', 'HLA-DMB', 'IL5', 'C7', 'GNLY', 'C9', 'HLA-DRA', 'VIM', 'HLA-DOA', 'HLA-DRB1', 'HLA-DPA1', 'C1QC']",0.03137985737731841,0,0,24
19,Apoptosis Modulation and Signaling WP1772,0.0011001920296077603,2.1023684827640117,14.321902883653133,"['TNFRSF11B', 'CASP7', 'BCL2L10', 'CAPNS1', 'CASP6', 'CASP10', 'BAG3', 'CASP4', 'PEA15', 'CASP1', 'TNFSF10', 'PMAIP1', 'MAPK3', 'JUN', 'ENDOG', 'CRADD', 'IL1R1', 'BIK', 'CDKN2A', 'IL1R2', 'TNFRSF10C', 'TNFRSF10B', 'TNFRSF10A', 'CFLAR', 'TNFRSF1B', 'TNFRSF10D', 'NFKBIA', 'TOLLIP', 'CYCS', 'BCL2L2', 'HSPA1A']",0.03393223838684987,0,0,31
20,Pre-implantation embryo WP3527,0.0019424914729604815,2.7526964465240975,17.187241659306437,"['EGR1', 'DLX2', 'TCF7L1', 'FOXD1', 'HMGA1', 'ATP1A1', 'GATA2', 'KLF4', 'AQP3', 'ZFP36L2', 'TBX3', 'SOX2', 'ZFP36', 'ARGFX', 'CDH1', 'DDIT3', 'FOSB']",0.05392291512909766,0,0,17
21,Peptide GPCRs WP24,0.0019663257070827527,2.483619047619048,15.476892146490338,"['CX3CR1', 'CCR1', 'OXTR', 'C5AR1', 'CXCR5', 'OPRL1', 'CXCR4', 'SSTR1', 'SSTR3', 'TSHR', 'HCRTR2', 'TRHR', 'HCRTR1', 'MC4R', 'CCKBR', 'FSHR', 'C3AR1', 'GNRHR', 'TAC4', 'NTSR1']",0.05392291512909766,0,0,20
22,Gastric acid production WP2596,0.0020244097830036663,inf,inf,"['GRP', 'CCK', 'VIP', 'MUC6']",0.05392291512909766,0,0,4
23,Thyroxine (Thyroid Hormone) Production WP1981,0.0021202143096805516,18.58890469416785,114.43772342583857,"['TPO', 'TG', 'TRH', 'CGA', 'TSHR']",0.05401937328142623,0,0,5
24,Inflammatory Response Pathway WP453,0.0026114251116525424,3.7212881162724423,22.1336977093681,"['CD86', 'ZAP70', 'COL3A1', 'IL4R', 'COL1A2', 'IL5', 'LAMB2', 'CD80', 'LAMC2', 'TNFRSF1B', 'THBS1']",0.06376229647618291,0,0,11
25,Role of Osx and miRNAs in tooth development WP3971,0.002815243119892666,6.508326216908625,38.22149068864859,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'ALPL', 'KLF4', 'BMP7', 'DKK1']",0.0659892987302841,0,0,7
26,Genes controlling nephrogenesis WP4823,0.0031988935411990296,2.792225392296719,16.041196097724903,"['NOTCH2', 'PDGFRB', 'FOXC1', 'EMX2', 'FOXD1', 'EYA1', 'LAMB2', 'CXCR4', 'ETV4', 'GLI3', 'PAX2', 'VEGFA', 'FGF8', 'KDR', 'ITGA8']",0.07012261115690134,0,0,15
27,Selenium Micronutrient Network WP15,0.0032309052922121777,2.061722831845474,11.823965812279267,"['SERPINA3', 'PLG', 'SELENOH', 'PRDX3', 'PRDX5', 'KYNU', 'RFK', 'ALOX5', 'PNPO', 'SEPHS2', 'XDH', 'ABCA1', 'GPX4', 'GPX3', 'DIO3', 'APOA1', 'KMO', 'ALOX15B', 'SOD3', 'F7', 'SELENOM', 'SELENOP', 'ALOX5AP', 'ALB', 'SELENOW', 'SELENOV']",0.07012261115690134,0,0,26
28,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.003938029358234733,4.185025633722586,23.172800156641525,"['TCF7L1', 'NOTCH1', 'EPAS1', 'LEF1', 'TNC', 'CXCR4', 'CYTIP', 'WNT2', 'VEGFA']",0.0794088344201321,0,0,9
29,Blood Clotting Cascade WP272,0.003938029358234733,4.185025633722586,23.172800156641525,"['F7', 'F8A1', 'SERPINB2', 'VWF', 'F12', 'SERPINF2', 'F11', 'PLG', 'F5']",0.0794088344201321,0,0,9
30,Imatinib and Chronic Myeloid Leukemia WP3640,0.00408202539716056,3.7205128205128206,20.467143722188677,"['PDGFRB', 'PDGFRA', 'CSF1R', 'LYL1', 'SPRED2', 'CDKN1B', 'FLT1', 'PIM1', 'PIM2', 'ABCG2']",0.0794088344201321,0,0,10
31,Irinotecan pathway WP229,0.004200808646798797,7.436539556061469,40.69630088116765,"['BCHE', 'SLCO1B1', 'ABCC2', 'CYP3A4', 'CYP3A5', 'ABCG2']",0.0794088344201321,0,0,6
32,Nuclear Receptors Meta-Pathway WP2882,0.004946471241450676,1.4556098604026027,7.727950416210676,"['SERPINA1', 'CDKN1B', 'SRXN1', 'TNFAIP3', 'SLC2A3', 'SLC7A11', 'SLC2A5', 'THBD', 'RGS2', 'ZIC2', 'SLCO2B1', 'ENC1', 'PDK4', 'CYP1B1', 'SLC39A7', 'JUNB', 'SLC39A3', 'SRGN', 'ABCC3', 'CPT1A', 'HSP90AA1', 'SERPINB2', 'ABCC2', 'SLC2A10', 'GPX3', 'HGF', 'SLC2A12', 'MYOF', 'CYP4A11', 'SLC39A11', 'APOA1', 'SLC39A12', 'CES4A', 'TGFBR2', 'TGFBR3', 'KAT2B', 'CYP2A6', 'B3GNT5', 'PPARA', 'EPHA2', 'FKBP5', 'AMIGO2', 'SLC5A11', 'TGFA', 'SLC5A2', 'ABCB11', 'CYP2C19', 'CYP3A4', 'SLC5A3', 'CYP3A5', 'EGFR', 'FOXO1', 'CYP3A7', 'PRRG4', 'FGD4', 'SLCO1B1', 'DNAJB1', 'SRPX2', 'HMOX1', 'STOM', 'HES1', 'IP6K3', 'CBR3', 'EGR1', 'JUN', 'SLC10A1', 'CAVIN2', 'VDR', 'PLK2', 'SOD3', 'SLC2A9', 'BHLHE40', 'ALOX5AP', 'HSPA1A']",0.09058225460906551,0,0,74
33,EDA signaling in hair follicle development WP3930,0.005522989245991636,5.206262453743239,27.066504853211836,"['EDA', 'PTCH1', 'SOSTDC1', 'LTB', 'GLI1', 'DKK1', 'RELB']",0.0951903440632676,0,0,7
34,Transcriptional cascade regulating adipogenesis WP4211,0.005522989245991636,5.206262453743239,27.066504853211836,"['CEBPA', 'CEBPB', 'EGR2', 'CEBPD', 'DDIT3', 'GATA2', 'KLF15']",0.0951903440632676,0,0,7
35,Pregnane X receptor pathway WP2876,0.006067025667668761,3.1482999758861827,16.07171498722909,"['ABCC3', 'SLCO1B1', 'HSP90AA1', 'CYP2A6', 'SRPX2', 'ABCC2', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1', 'CYP3A7']",0.09879657850892043,0,0,11
36,Drug Induction of Bile Acid Pathway WP2289,0.0061923318125100876,4.2505694760820045,21.611780585560727,"['ABCC3', 'SLCO1B1', 'ABCC2', 'VDR', 'SLC10A1', 'SLC51A', 'CYP3A4', 'ABCB11']",0.09879657850892043,0,0,8
37,Differentiation of white and brown adipocyte WP2895,0.0063268554674963205,3.382025382025382,17.1230319448519,"['PLAC8', 'CEBPA', 'CEBPB', 'LEP', 'ZIC1', 'PRDM16', 'EBF3', 'SLC7A10', 'ZNF423', 'BMP7']",0.09879657850892043,0,0,10
38,Complement Activation WP545,0.006406604067131359,3.7197379663913415,18.786261097443937,"['C1QB', 'C3', 'C1QA', 'C6', 'C7', 'C1R', 'C9', 'MASP2', 'C1QC']",0.09879657850892043,0,0,9
39,Differentiation Pathway WP2848,0.008003087294774324,2.4274638714879364,11.71962055115669,"['CSF1R', 'NOTCH1', 'CSF1', 'HGF', 'FST', 'FLT3LG', 'FGF2', 'DKK1', 'VEGFA', 'TPO', 'TF', 'FGF8', 'WNT2', 'NODAL', 'FGF10']",0.12025151678814754,0,0,15
40,Myometrial relaxation and contraction pathways WP289,0.00900278853092553,1.587871643074575,7.479226220156623,"['RYR1', 'RGS18', 'OXTR', 'RAMP2', 'RGS14', 'YWHAB', 'LPAR1', 'ADCY4', 'ITPR2', 'ATP2A2', 'RXFP2', 'ETS2', 'ACTB', 'RYR3', 'ACTG1', 'RGS4', 'CNN2', 'CNN1', 'GJA1', 'RGS2', 'GNG3', 'PLCG2', 'RGS20', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP2', 'GNG12', 'GNG11', 'ACTA2', 'CREB3', 'ACTA1', 'ACTC1', 'PRKAR1A', 'CRH', 'RGS10', 'CALM3', 'CALM1', 'CALM2']",0.13189085197805903,0,0,43
41,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.01235793937135088,2.7281086729362594,11.985826941084484,"['RAB3B', 'FGD4', 'EGR2', 'RAB3A', 'RAB25', 'SH3TC2', 'HSPB1', 'NEFL', 'MFN2', 'LITAF', 'RAB11A']",0.17242267789551466,0,0,11
42,Purinergic signaling WP4900,0.01235793937135088,2.7281086729362594,11.985826941084484,"['P2RY8', 'P2RX7', 'GNAZ', 'P2RY6', 'ADORA2A', 'GNAT3', 'ADORA2B', 'ADORA3', 'P2RY14', 'P2RX1', 'P2RY1']",0.17242267789551466,0,0,11
43,Toll-like Receptor Signaling related to MyD88 WP3858,0.015092947348328703,2.4802356518434054,10.400936926623112,"['TLR1', 'TICAM2', 'TOLLIP', 'IRF7', 'TLR9', 'TLR7', 'TLR6', 'TLR5', 'TLR4', 'TLR3', 'RELB', 'TLR2']",0.2056852824679214,0,0,12
44,Cytokines and Inflammatory Response WP530,0.016037077473313385,3.718189581554227,15.366726860164922,"['IL5', 'CSF1', 'IL15', 'IL7', 'HLA-DRA', 'CXCL1', 'HLA-DRB1']",0.20883838665248097,0,0,7
45,Nephrogenesis WP5052,0.016037077473313385,3.718189581554227,15.366726860164922,"['NOTCH2', 'MEIS1', 'FOXD1', 'FGF8', 'ALDH1A2', 'BMP7', 'PAX2']",0.20883838665248097,0,0,7
46,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.01693246564864035,2.5574059561128526,10.430437620093281,"['CXCL1', 'OLIG1', 'SOX9', 'OLIG2', 'ASCL1', 'FGF2', 'SOX10', 'MYT1', 'GLI2', 'NKX2-2', 'SOX5']",0.21570488848050534,0,0,11
47,PI3K-Akt signaling pathway WP4172,0.018222745063651156,1.3434206204651995,5.3805134215745225,"['CDKN1B', 'CHRM1', 'CSF3R', 'FLT1', 'CSF1', 'ITGB5', 'ITGB4', 'TNC', 'LAMC2', 'FGF2', 'GYS2', 'CCND3', 'FGF8', 'CREB3L1', 'CREB3L2', 'KDR', 'TNR', 'ITGB8', 'HRAS', 'PDGFRB', 'PDGFRA', 'HSP90AA1', 'IL4R', 'SYK', 'VWF', 'HGF', 'ITGA2', 'FLT3LG', 'OSMR', 'PRLR', 'CREB3', 'COL4A6', 'ITGA8', 'COL4A5', 'ITGA6', 'COL6A6', 'SGK1', 'TLR4', 'EPHA2', 'TLR2', 'CSF1R', 'PHLPP1', 'PKN3', 'LAMA4', 'LPAR1', 'TGFA', 'LPAR3', 'THBS1', 'PIK3R6', 'EGFR', 'THBS4', 'PIK3R5', 'GNG10', 'GNG3', 'RELN', 'SPP1', 'MAPK3', 'NTRK1', 'NGFR', 'LAMB3', 'LAMB2', 'VEGFC', 'GNG12', 'GNG11', 'VEGFA', 'FGF17', 'EFNA3', 'COL1A2', 'LPAR5', 'IL7', 'ITGA10', 'CDK2', 'COL9A1', 'COL9A2', 'FGFR4', 'PIK3AP1', 'FGF10']",0.22720273632552293,0,0,77
48,Composition of Lipid Particles WP3601,0.020975846875779747,7.43287827076223,28.723493276540783,"['APOA1', 'LPL', 'LCAT', 'APOE']",0.25608013060847773,0,0,4
49,Regulation of toll-like receptor signaling pathway WP1449,0.021571616749958878,1.5638993363223617,5.999707237360671,"['CD86', 'SFTPA2', 'CD80', 'PELI3', 'PELI2', 'LY96', 'TNFAIP3', 'PIK3R5', 'TIFA', 'CCL3', 'SPP1', 'MAP3K8', 'CD14', 'MAPK3', 'JUN', 'TICAM2', 'CISH', 'SYK', 'CD180', 'IRAK3', 'SMAD6', 'NFKBIA', 'TLR1', 'TOLLIP', 'BTK', 'IRF7', 'TLR9', 'TLR7', 'PTPN6', 'TLR6', 'TLR5', 'TLR4', 'TLR3', 'TLR2']",0.257978926846447,0,0,34
50,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.02265856594427856,2.4067859118569057,9.11502126964662,"['GGT5', 'CYSLTR1', 'CYSLTR2', 'HPGD', 'TRPA1', 'ALOX5', 'ALOX15', 'CYP4A11', 'LTC4S', 'PPARA', 'ALOX15B']",0.26347452463092813,0,0,11
51,BMP Signaling Pathway in Eyelid Development WP3927,0.02293037671702617,2.974715261958998,11.230420971440598,"['FOXC1', 'JUN', 'NOTCH1', 'TGFA', 'INHBB', 'EGFR', 'MAPK3', 'FGF10']",0.26347452463092813,0,0,8
52,Fatty Acid Omega Oxidation WP206,0.025054226075830615,4.646159317211949,17.129054840029866,"['CYP2A6', 'ADH1B', 'CYP4A11', 'ALDH1A1', 'CYP3A4']",0.26847452926306353,0,0,5
53,Nucleotide GPCRs WP80,0.025054226075830615,4.646159317211949,17.129054840029866,"['P2RY6', 'ADORA2A', 'ADORA2B', 'ADORA3', 'P2RY1']",0.26847452926306353,0,0,5
54,PTF1A related regulatory pathway WP4147,0.025054226075830615,4.646159317211949,17.129054840029866,"['KAT2B', 'NOTCH1', 'HES1', 'PTF1A', 'FGF10']",0.26847452926306353,0,0,5
55,Computational Model of Aerobic Glycolysis WP4629,0.025656269008074335,3.717416050085373,13.616773548888109,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH']",0.26847452926306353,0,0,6
56,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.025656269008074335,3.717416050085373,13.616773548888109,"['ZAP70', 'HLA-DRB5', 'CD8B', 'HLA-DRA', 'CD247', 'HLA-DRB1']",0.26847452926306353,0,0,6
57,Oxidation by Cytochrome P450 WP43,0.027027804427303768,1.9932239657631954,7.197310789994702,"['CYP2J2', 'CYP4A11', 'CYP3A4', 'CYP2C19', 'CYP4F11', 'CYP3A5', 'CYP19A1', 'CYP2C18', 'CYP3A7', 'CYP27A1', 'CYP39A1', 'CYP26B1', 'CYP2A6', 'CYP11A1', 'CYP1B1']",0.27406890930080163,0,0,15
58,Neural Crest Differentiation WP2064,0.027126274299396746,1.6408758840821553,5.919053617726241,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'DLX5', 'WNT8A', 'ASCL1', 'FGF2', 'FGF8', 'CDH1', 'HEY2', 'ZIC1', 'HES1', 'SOX9', 'MSX1', 'HES5', 'SOX5', 'TCF7L1', 'MIA', 'OLIG1', 'OLIG2', 'ZIC5', 'TBX6', 'SOX10', 'BMP7', 'GFAP', 'PAX7']",0.27406890930080163,0,0,26
59,Eicosanoid Synthesis WP167,0.028909029654630106,2.57441447757597,9.122698458243129,"['PTGES2', 'ALOX5', 'ALOX15', 'ALOX5AP', 'TBXAS1', 'PLA2G5', 'LTC4S', 'ALOX15B', 'PTGES']",0.28234485629355405,0,0,9
60,Statin inhibition of cholesterol production WP430,0.028909029654630106,2.57441447757597,9.122698458243129,"['ABCA1', 'APOC2', 'APOC1', 'LCAT', 'LPL', 'APOA1', 'HMGCR', 'APOE', 'ACSS1']",0.28234485629355405,0,0,9
61,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.029678537421920594,2.2729014280738418,7.9945469714199495,"['IFIH1', 'OAS1', 'OAS2', 'OAS3', 'IRF7', 'TLR9', 'TLR7', 'TLR6', 'TLR4', 'TLR3', 'TLR2']",0.2851085726105814,0,0,11
62,Pathogenic Escherichia coli infection WP2272,0.030244786420849656,1.8605481016271768,6.5090000098700145,"['TUBB', 'ARPC5L', 'LY96', 'TUBB4B', 'ACTB', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBA1C', 'TUBB2A', 'CDH1', 'TUBB3', 'HCLS1', 'CD14', 'TLR5', 'EZR', 'TLR4']",0.28586201359061125,0,0,17
63,TGF-beta Receptor Signaling WP560,0.03489307518054896,1.8603025114155252,6.242183479381856,"['JUN', 'FST', 'LEF1', 'SMAD6', 'RUNX3', 'LTBP1', 'THBS1', 'TGFBR2', 'TGFBR3', 'FKBP1A', 'BAMBI', 'SPP1', 'ZNF423', 'HRAS', 'ENG', 'MAPK3']",0.3245609850127253,0,0,16
64,Monoamine GPCRs WP58,0.0381228346889818,2.15311004784689,7.034085302965323,"['CHRM1', 'HTR7', 'HTR1E', 'HTR1D', 'HTR2B', 'ADRB1', 'ADRA1D', 'ADRB2', 'HTR5A', 'DRD3', 'DRD5']",0.3285298713939603,0,0,11
65,Sleep regulation WP3591,0.0381228346889818,2.15311004784689,7.034085302965323,"['CHRNB2', 'OXTR', 'AHCY', 'STAR', 'ADORA2A', 'CRH', 'UTS2', 'DRD3', 'HCRTR2', 'PTGDR', 'HCRTR1']",0.3285298713939603,0,0,11
66,Constitutive Androstane Receptor Pathway WP2875,0.03878099427980882,2.390344631159214,7.768201718277558,"['ABCC3', 'HSP90AA1', 'CYP2A6', 'ABCC2', 'CYP4A11', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1']",0.3285298713939603,0,0,9
67,Farnesoid X receptor pathway WP2879,0.03925522728813291,3.1861126920887877,10.315583596348274,"['SLC10A1', 'SLCO2B1', 'CYP3A4', 'ABCB11', 'IP6K3', 'FKBP5']",0.3285298713939603,0,0,6
68,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.03925522728813291,3.1861126920887877,10.315583596348274,"['ABCA1', 'LIPG', 'LPL', 'APOA1', 'LCAT', 'APOE']",0.3285298713939603,0,0,6
69,Lung fibrosis WP3624,0.04030876897208414,1.8600570613409415,5.972989643485112,"['CEBPB', 'SERPINA1', 'SFTPA2', 'HGF', 'MMP2', 'TGFA', 'FGF2', 'BMP7', 'CYSLTR2', 'IL5', 'TERT', 'CCL3', 'SPP1', 'HMOX1', 'PTX3']",0.3285298713939603,0,0,15
70,Codeine and Morphine Metabolism WP1604,0.040786277179032784,4.9548729616989,15.852668109536152,"['ABCC3', 'SLCO1B1', 'ABCC2', 'CYP3A4']",0.3285298713939603,0,0,4
71,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.040786277179032784,4.9548729616989,15.852668109536152,"['CD86', 'IL5', 'CD80', 'VIP']",0.3285298713939603,0,0,4
72,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.040786277179032784,4.9548729616989,15.852668109536152,"['HEY1', 'VEGFC', 'HES1', 'VEGFA']",0.3285298713939603,0,0,4
73,Gene regulatory network modelling somitogenesis  WP2854,0.04148670730913492,3.716642958748222,11.8277784285989,"['LFNG', 'NOTCH1', 'FGF8', 'HES1', 'TBX6']",0.3285298713939603,0,0,5
74,Tamoxifen metabolism WP691,0.04148670730913492,3.716642958748222,11.8277784285989,"['CYP2A6', 'CYP1B1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.3285298713939603,0,0,5
75,Metapathway biotransformation Phase I and II WP702,0.047305017140925755,1.42627696216137,4.351769147777221,"['GAL3ST1', 'GLYAT', 'CYP2C19', 'CYP3A4', 'CYP19A1', 'CYP2C18', 'CYP3A5', 'NAA80', 'CYP3A7', 'SULT1C2', 'CYP26B1', 'CHST11', 'CYP11A1', 'CYP1B1', 'CHST13', 'CHST14', 'GAL3ST2', 'SULT4A1', 'GAL3ST4', 'SULT1C4', 'CYP2J2', 'HS3ST3B1', 'GPX4', 'GPX3', 'EPHX1', 'FMO2', 'CYP4F11', 'FMO4', 'HS3ST4', 'CYP27A1', 'CYP39A1', 'SULT1B1', 'CYP2A6', 'NAT8L', 'CHST2', 'CHST3']",0.3696098672610999,0,0,36
76,Cancer immunotherapy by PD-1 blockade WP4585,0.05023019851903585,2.602134927412468,7.7833469238372235,"['ZAP70', 'JUN', 'CD8B', 'NFATC2', 'NFATC1', 'HLA-DRB1', 'BATF']",0.3752364443739878,0,0,7
77,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.05023019851903585,2.602134927412468,7.7833469238372235,"['SPP1', 'KDR', 'HSPB1', 'PDLIM5', 'TLR4', 'EGFR', 'ETS2']",0.3752364443739878,0,0,7
78,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.05087921471337502,1.2732131495227996,3.792011734361063,"['CDKN1B', 'CHRM1', 'CSF3R', 'FLT1', 'CSF1', 'ITGB5', 'ITGB4', 'ITGB2', 'TNC', 'LAMC2', 'SLC2A3', 'HIF3A', 'FGF2', 'GYS2', 'FGF8', 'CREB3L1', 'CREB3L2', 'KDR', 'ITGAX', 'TNR', 'ITGB8', 'PELO', 'HRAS', 'PDGFRB', 'PDGFRA', 'HSP90AA1', 'IL4R', 'VWF', 'HGF', 'ITGA2', 'OSMR', 'PRLR', 'CREB3', 'COL4A6', 'ITGA8', 'ITGA6', 'EPHA2', 'PFKFB1', 'CSF1R', 'PHLPP1', 'EPAS1', 'LAMA4', 'LPAR1', 'LPAR3', 'THBS1', 'EGFR', 'FOXO1', 'THBS4', 'PIK3R5', 'GNG10', 'GNG3', 'RELN', 'SPP1', 'MAPK3', 'NGFR', 'LAMB3', 'LAMB2', 'VEGFC', 'GNG12', 'GNG11', 'VEGFA', 'FGF17', 'COL3A1', 'EFNA3', 'COL1A2', 'LPAR5', 'COL5A3', 'ITGA10', 'FGFR4', 'FGF10']",0.3752364443739878,0,0,70
79,Modulators of TCR signaling and T cell activation WP5072,0.05101821978450208,1.7092993650230304,5.086144115398471,"['CDKN1B', 'NDUFB10', 'TNFAIP3', 'RHOH', 'VAV1', 'ZFP36L1', 'NFKBIA', 'ZAP70', 'FIBP', 'CD5', 'ELOB', 'MAP3K8', 'LCP2', 'PTPN6', 'CD247', 'MEF2D', 'CARD11']",0.3752364443739878,0,0,17
80,Endochondral Ossification with Skeletal Dysplasias WP4808,0.05186715357387885,1.6742004568817819,4.9540756231574,"['HMGCS1', 'PTCH1', 'PTH1R', 'FGF2', 'RUNX3', 'BMP7', 'GLI3', 'VEGFA', 'ACAN', 'SCIN', 'CHST11', 'SERPINH1', 'SPP1', 'ALPL', 'SOX9', 'CALM1', 'CALM2', 'SOX5']",0.3752364443739878,0,0,18
81,Endochondral Ossification WP474,0.05186715357387885,1.6742004568817819,4.9540756231574,"['HMGCS1', 'PTCH1', 'PTH1R', 'FGF2', 'RUNX3', 'BMP7', 'GLI3', 'VEGFA', 'ACAN', 'SCIN', 'CHST11', 'SERPINH1', 'SPP1', 'ALPL', 'SOX9', 'CALM1', 'CALM2', 'SOX5']",0.3752364443739878,0,0,18
82,Ovarian infertility WP34,0.055780475784537445,2.0656853434631213,5.962252401514773,"['EGR1', 'CEBPB', 'CDKN1B', 'VDR', 'FSHR', 'GJA4', 'PGR', 'BMPR1B', 'CYP19A1', 'PRLR']",0.38497536768835705,0,0,10
83,Hippo-Merlin Signaling Dysregulation WP4541,0.05614522785569003,1.4426017483519633,4.154424120759725,"['CSF1R', 'FLT1', 'ITGAM', 'ITGB5', 'ITGB4', 'ITGB2', 'FOXM1', 'EGFR', 'CDH5', 'CDH1', 'CDH20', 'KDR', 'ITGAX', 'ITGB8', 'HRAS', 'TEAD2', 'TEAD3', 'PDGFRB', 'NTRK1', 'PDGFRA', 'NGFR', 'ITGA2', 'LATS2', 'PRKAR1A', 'ITGA10', 'ITGA8', 'ITGA6', 'FGFR4', 'CD44', 'EPHA2', 'CDH19']",0.38497536768835705,0,0,31
84,Cells and molecules involved in local acute inflammatory response  WP4493,0.05666885797403215,2.7876351735913487,8.001991680555792,"['SELP', 'C3', 'SELPLG', 'C6', 'C7', 'ITGB2']",0.38497536768835705,0,0,6
85,Hedgehog Signaling Pathway Netpath WP47,0.05666885797403215,2.7876351735913487,8.001991680555792,"['SMO', 'PTCH1', 'SUFU', 'GLI1', 'GLI3', 'GLI2']",0.38497536768835705,0,0,6
86,Small Ligand GPCRs WP247,0.05666885797403215,2.7876351735913487,8.001991680555792,"['PTGIR', 'CNR2', 'PTAFR', 'LPAR1', 'S1PR1', 'PTGDR']",0.38497536768835705,0,0,6
87,Globo Sphingolipid Metabolism WP1424,0.058543609349067535,2.2877168389696863,6.492502283645995,"['B3GALNT1', 'ST6GAL1', 'ST6GAL2', 'FUT2', 'ST6GALNAC3', 'A4GALT', 'FUT1', 'ABO']",0.38497536768835705,0,0,8
88,Kallmann's Syndrome WP5074,0.058543609349067535,2.2877168389696863,6.492502283645995,"['PROKR2', 'FGF8', 'TMEM98', 'CHD7', 'SEMA3E', 'OLIG2', 'ASCL1', 'SOX10']",0.38497536768835705,0,0,8
89,Glucocorticoid Receptor Pathway WP2880,0.06072333568372338,1.6065215133338526,4.500553083957784,"['SRGN', 'HSP90AA1', 'MGAM', 'JUN', 'CAVIN2', 'PLK2', 'AMIGO2', 'TNFAIP3', 'TGFBR3', 'PRRG4', 'THBD', 'FGD4', 'RGS2', 'ZIC2', 'B3GNT5', 'ENC1', 'ALOX5AP', 'BHLHE40', 'STOM']",0.38497536768835705,0,0,19
90,Cardiac Progenitor Differentiation WP2406,0.0627527644283119,1.8593215507411631,5.147629601497856,"['SOX2', 'MESP1', 'PDGFRA', 'NOTCH1', 'ACTC1', 'KDR', 'CXCR4', 'PAX6', 'THY1', 'FGF2', 'DKK1', 'NODAL']",0.38497536768835705,0,0,12
91,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.0627527644283119,1.8593215507411631,5.147629601497856,"['CREB3', 'STAR', 'CYP11A1', 'CREB3L1', 'CREB3L2', 'HSD3B1', 'ITPR2', 'CALM3', 'REN', 'CALM1', 'CALM2', 'AGT']",0.38497536768835705,0,0,12
92,Tryptophan metabolism WP465,0.0627527644283119,1.8593215507411631,5.147629601497856,"['CYP2J2', 'TPH1', 'HAAO', 'KYNU', 'ALDH1A2', 'ALDH1A1', 'CYP1B1', 'DHCR24', 'CYP3A4', 'CYP19A1', 'CYP2C18', 'ACMSD']",0.38497536768835705,0,0,12
93,Biogenic Amine Synthesis WP550,0.06306763702744415,3.0969653864390705,8.558611028334523,"['TPH1', 'GAD1', 'PAH', 'GAD2', 'DBH']",0.38497536768835705,0,0,5
94,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.06306763702744415,3.0969653864390705,8.558611028334523,"['HSD11B2', 'STAR', 'CYP11A1', 'HSD3B1', 'CYP19A1']",0.38497536768835705,0,0,5
95,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.06306763702744415,3.0969653864390705,8.558611028334523,"['TPO', 'CSF1', 'FLT3LG', 'IRF8', 'IKZF1']",0.38497536768835705,0,0,5
96,Glycolysis in senescence WP5049,0.06306763702744415,3.0969653864390705,8.558611028334523,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'GAPDH']",0.38497536768835705,0,0,5
97,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.06767997797547584,5.573073642308786,15.008091643137858,"['NRP1', 'KDR', 'VEGFA']",0.4031183031278524,0,0,3
98,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.06767997797547584,5.573073642308786,15.008091643137858,"['MAS1', 'REN', 'AGT']",0.4031183031278524,0,0,3
99,HIF1A and PPARG regulation of glycolysis WP2456,0.06810360411204332,3.7158703071672354,9.98352218391141,"['LDHA', 'TPI1', 'GPD1', 'GAPDH']",0.4031183031278524,0,0,4
100,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.06891208275539483,1.6530948756976154,4.421902743653074,"['JUN', 'FST', 'LEF1', 'SMAD6', 'RUNX3', 'LTBP1', 'THBS1', 'TGFBR2', 'TGFBR3', 'FKBP1A', 'BAMBI', 'SPP1', 'ZNF423', 'HRAS', 'ENG', 'MAPK3']",0.4038248049466137,0,0,16
101,NRF2 pathway WP2884,0.07500191105751802,1.3850010667804566,3.5874874969491226,"['SERPINA1', 'SRXN1', 'SLC5A11', 'TGFA', 'SLC2A3', 'SLC7A11', 'SLC5A2', 'SLC2A5', 'SLC5A3', 'DNAJB1', 'HMOX1', 'SLC39A7', 'SLC39A3', 'CBR3', 'ABCC3', 'EGR1', 'HSP90AA1', 'ABCC2', 'GPX3', 'SLC2A10', 'HGF', 'CYP4A11', 'SLC2A12', 'SLC39A11', 'SLC39A12', 'SOD3', 'CES4A', 'TGFBR2', 'SLC2A9', 'CYP2A6', 'EPHA2', 'HSPA1A']",0.4312846684613686,0,0,32
102,IL-18 signaling pathway WP4754,0.07563865885134202,1.2636511363137286,3.2624790442638987,"['SPON1', 'CD83', 'NCF1', 'HSPB1', 'TNFAIP3', 'CXCL16', 'EPS8', 'PPP1R13L', 'TMSB4X', 'FAM186B', 'STMN1', 'TGM2', 'CPT1A', 'TICAM2', 'USP5', 'MMP2', 'BPGM', 'KRT31', 'ACTA2', 'CCNA2', 'ARL4D', 'ACTA1', 'MMP14', 'LTB', 'ARF6', 'MYH7', 'CEBPB', 'NRN1', 'STOML1', 'SDC4', 'MEPCE', 'TNFRSF11B', 'GATA1', 'ACACB', 'FUT1', 'SOCS3', 'PTPRZ1', 'SPP1', 'CCL3', 'HMOX1', 'MAPK3', 'SLC12A3', 'JUN', 'CFLAR', 'VEGFA', 'NFKBIA', 'NR4A1', 'TF', 'COL3A1', 'COL1A2', 'TNIP3', 'CYCS', 'PTX3', 'NFKBIE', 'IL18R1', 'CDK5R2', 'SNTB1', 'ITM2C']",0.4312846684613686,0,0,58
103,Cori Cycle WP1946,0.0780139502677561,2.477708214760008,6.320305653612366,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.4312846684613686,0,0,6
104,Development and heterogeneity of the ILC family WP3893,0.0780139502677561,2.477708214760008,6.320305653612366,"['IL33', 'IL5', 'NFIL3', 'IL15', 'IL7', 'RORA']",0.4312846684613686,0,0,6
105,Platelet-mediated interactions with vascular and circulating cells WP4462,0.0780139502677561,2.477708214760008,6.320305653612366,"['SELP', 'SELPLG', 'TLR7', 'SELE', 'TLR4', 'TLR2']",0.4312846684613686,0,0,6
106,Selective expression of chemokine receptors during T-cell polarization WP4494,0.0780139502677561,2.477708214760008,6.320305653612366,"['CCR1', 'IL4R', 'IL5', 'CCL3', 'CXCR4', 'IL18R1']",0.4312846684613686,0,0,6
107,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.08002230342691896,1.6082932247315809,4.061663948012462,"['CEBPA', 'CEBPB', 'TCF7L1', 'NOTCH1', 'ICMT', 'MSTN', 'CEBPD', 'LEF1', 'HMGA2', 'TNFRSF11B', 'ACTB', 'KAT2B', 'SPP1', 'HES1', 'JUNB', 'HES5']",0.43825298886144404,0,0,16
108,Calcium Regulation in the Cardiac Cell WP536,0.08710188528521269,1.3220353540504706,3.22666095169549,"['RYR1', 'RGS18', 'GNAZ', 'CHRM1', 'RGS14', 'YWHAB', 'ADCY4', 'ITPR2', 'ATP2A2', 'ADRB1', 'ADRA1D', 'ADRB2', 'RYR3', 'RGS4', 'GJA1', 'RGS2', 'GNG3', 'PLN', 'GJA4', 'RGS20', 'YWHAG', 'YWHAH', 'PRKCH', 'ATP1B1', 'GNG12', 'GNG11', 'GJD2', 'FKBP1A', 'SLC8A3', 'PRKAR1A', 'GJB3', 'FXYD2', 'GJB6', 'RGS10', 'CALM3', 'CASQ1', 'CALM1', 'CALM2']",0.47260837756606144,0,0,38
109,Kynurenine Pathway and links to Cellular Senescence WP5044,0.08813736554929313,2.1681136730240063,5.266041777701264,"['IL1R2', 'HAAO', 'KYNU', 'KMO', 'TLR4', 'FOXO1', 'ACMSD']",0.47383941478794295,0,0,7
110,Vitamin B12 metabolism WP1533,0.09003711220507754,1.7160336812560302,4.131408293003172,"['ABCA1', 'SERPINA3', 'CUBN', 'F7', 'TCN2', 'TCN1', 'ALB', 'APOA1', 'PLG', 'LRP2', 'APOE', 'SOD3']",0.47965225229250397,0,0,12
111,B Cell Receptor Signaling Pathway WP23,0.09361870513839946,1.4092643169896388,3.337877871024445,"['GSK3A', 'DAPP1', 'ELK1', 'FOXO1', 'INPP5D', 'SH3BP2', 'PLCG2', 'BLNK', 'HRAS', 'MEF2D', 'LYN', 'JUN', 'SYK', 'GAB1', 'NFATC2', 'VAV1', 'NFKBIA', 'PTPRC', 'BCL6', 'BTK', 'HCLS1', 'PTPN6', 'PIK3AP1', 'CARD11', 'CD22']",0.4925637548133467,0,0,25
112,Adipogenesis WP236,0.09414187805306286,1.3614158920958837,3.216960804815517,"['CEBPA', 'CEBPB', 'CEBPD', 'EPAS1', 'UCP1', 'LPL', 'RORA', 'GATA2', 'FOXO1', 'SOCS3', 'CYP26B1', 'NDN', 'MEF2D', 'STAT5A', 'GDF10', 'WWTR1', 'EGR2', 'EBF1', 'HMGA1', 'LIFR', 'MIF', 'PRLR', 'KLF15', 'AGT', 'SFRP4', 'DDIT3', 'LEP', 'ID3', 'PPARA', 'LPIN3']",0.4925637548133467,0,0,30
113,Bile acids synthesis and enterohepatic circulation  WP4389,0.10254313245562466,2.9724687144482367,6.769713567931992,"['SLC10A1', 'FGFR4', 'ABCB11', 'MAPK3']",0.5153194020699047,0,0,4
114,Estrogen Receptor Pathway WP2881,0.10254313245562466,2.9724687144482367,6.769713567931992,"['JUN', 'PDK4', 'CYP1B1', 'PPARA']",0.5153194020699047,0,0,4
115,Tgif disruption of Shh signaling WP3674,0.10254313245562466,2.9724687144482367,6.769713567931992,"['TGIF2', 'FGF8', 'NODAL', 'GLI3']",0.5153194020699047,0,0,4
116,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.10288800348494684,1.7701804368471035,4.025592516051441,"['ITGAM', 'TICAM2', 'TYROBP', 'SYK', 'ITGB2', 'LY96', 'PLG', 'CD14', 'TLR4', 'TLR3']",0.5153194020699047,0,0,10
117,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.10288800348494684,1.7701804368471035,4.025592516051441,"['PDGFRA', 'EDA', 'SMO', 'CDH1', 'PTCH1', 'GJB6', 'LEF1', 'LRP5', 'GLI1', 'GLI2']",0.5153194020699047,0,0,10
118,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.1065447429528011,1.611130120710959,3.607626874591847,"['ITGB5', 'ITGB4', 'ITGB2', 'LIMD1', 'ACTB', 'ACTG1', 'ACTA2', 'ACTA1', 'ACTC1', 'CDH1', 'ITGB8', 'TEAD2', 'TEAD3']",0.5291120285622156,0,0,13
119,Ebola Virus Pathway on Host WP4217,0.11031705661135432,1.3258154528353479,2.922623243929043,"['VPS4A', 'ICAM2', 'ACTB', 'ASGR1', 'EGFR', 'ACTG1', 'RELB', 'SOCS3', 'SCIN', 'HLA-DMB', 'HLA-DOA', 'HLA-DPA1', 'MAPK3', 'VPS18', 'HLA-DRB5', 'GSN', 'CAV3', 'CD300A', 'ITGA2', 'RHOC', 'MERTK', 'HLA-E', 'BST2', 'AXL', 'NEDD4', 'IRF7', 'HLA-DRA', 'ITGA6', 'TLR4', 'CLEC4G', 'HLA-DRB1']",0.5432419762542322,0,0,31
120,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.11142183242030895,1.4201148380056638,3.1163454278091267,"['TCF7L1', 'WNT10A', 'JUN', 'FZD2', 'CSNK2A3', 'SERPINF1', 'LEF1', 'LRP5', 'FZD9', 'WNT16', 'KLF4', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'CCND3', 'FRAT2', 'SFRP2', 'WIF1', 'WNT2']",0.5441099483191755,0,0,21
121,FTO Obesity Variant Mechanism WP3407,0.1143841467476305,3.715098094967302,8.055048892579936,"['TBX1', 'PRDM16', 'UCP1']",0.544952113773264,0,0,3
122,let-7 inhibition of ES cell reprogramming WP3299,0.1143841467476305,3.715098094967302,8.055048892579936,"['SOX2', 'EGR1', 'KLF4']",0.544952113773264,0,0,3
123,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.1143841467476305,3.715098094967302,8.055048892579936,"['ROBO4', 'KDR', 'VEGFA']",0.544952113773264,0,0,3
124,"COVID-19, thrombosis and anticoagulation WP4927",0.11594728941204618,7.429221148379761,16.007145445303674,"['F13A1', 'PLG']",0.5479444483504763,0,0,2
125,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.11721892430857682,1.8583428246013667,3.983751710379397,"['NFKBIA', 'ZAP70', 'GSK3A', 'CD8B', 'NFATC2', 'PTPN6', 'CALM1', 'CALM2']",0.5495223171586081,0,0,8
126,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.12137435132099675,2.3223684210526314,4.897586322185625,"['RYR1', 'CCKBR', 'CD38', 'CCK', 'RYR3']",0.5608824815362022,0,0,5
127,Toll-like Receptor Signaling Pathway WP75,0.12155644224419401,1.38684575205202,2.9226062563514255,"['CD86', 'JUN', 'TICAM2', 'CD80', 'LY96', 'PIK3R5', 'NFKBIA', 'TLR1', 'TOLLIP', 'IRF7', 'TLR9', 'CCL3', 'SPP1', 'MAP3K8', 'TLR7', 'CD14', 'TLR6', 'TLR5', 'TLR4', 'TLR3', 'TLR2', 'MAPK3']",0.5608824815362022,0,0,22
128,Mesodermal commitment pathway WP2857,0.13459535132454717,1.278884069400631,2.5647794919698876,"['YAP1', 'FOXC1', 'LEF1', 'SOX21', 'SOX2', 'FGF8', 'ZIC2', 'ZIC3', 'RPL38', 'TEAD2', 'VAV3', 'TBX1', 'ZNF462', 'TCF7L1', 'SLC2A12', 'PBX3', 'HMGA2', 'PAX6', 'ZIC5', 'TBX6', 'SMAD6', 'KLF4', 'DKK1', 'ZFHX4', 'BMP7', 'GRHL2', 'TBX3', 'ARL4A', 'MEIS1', 'PRKAR1A', 'BHLHE40', 'RGS10', 'NODAL']",0.6161943427826925,0,0,33
129,miRNA targets in ECM and membrane receptors WP2911,0.1384080384554516,1.858098491317962,3.6744811035674574,"['COL3A1', 'COL1A2', 'ITGB5', 'LAMB2', 'LAMA4', 'COL5A3', 'THBS1']",0.6287372909681755,0,0,7
130,Canonical and non-canonical Notch signaling WP3845,0.14188164313496546,1.74889454642905,3.415174931170531,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'MAML2', 'HEY1', 'LEF1', 'HES1', 'DLK2']",0.6393797393041605,0,0,8
131,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.14364879789203447,1.5725825898239691,3.0514138788048126,"['NFKBIA', 'CASP7', 'HSP90AA1', 'CASP5', 'CARD8', 'CASP1', 'CARD6', 'ERBIN', 'NLRC4', 'NOD2', 'AAMP']",0.6393797393041605,0,0,11
132,The influence of laminopathies on Wnt signaling WP4844,0.1440241050992307,1.6160039638300507,3.1314514295881626,"['CEBPA', 'CEBPB', 'TCF7L1', 'ICMT', 'CEBPD', 'LEF1', 'SPP1', 'HMGA2', 'HES1', 'HES5']",0.6393797393041605,0,0,10
133,VEGFA-VEGFR2 Signaling Pathway WP3888,0.14628187665281492,1.1399449447097063,2.1912248081526506,"['NCF1', 'ARPC5L', 'RPL10A', 'ELK1', 'RPL7', 'ACTG1', 'TUBB8', 'CDH5', 'GJA1', 'RPS6KA5', 'RPL18A', 'KDR', 'CHAC1', 'ATP6V1E1', 'IER5', 'TMSB10', 'CYBB', 'DKK1', 'KATNAL2', 'TXNIP', 'RPL26', 'ERG', 'EZR', 'ATP6V0D1', 'DSC1', 'EPHA2', 'SET', 'HTRA1', 'PLA2G5', 'FOXO4', 'ADRB2', 'GATA2', 'ACACB', 'FUT1', 'FOXO1', 'LDHA', 'PGK1', 'IGFBP7', 'EGR1', 'JUN', 'EGR3', 'TNFRSF10C', 'NFATC2', 'NFATC1', 'BMX', 'SELE', 'QKI', 'NFKBIA', 'NR4A1', 'NR4A3', 'ALB', 'CYCS', 'HYOU1', 'EIF4G2', 'FLT1', 'ITGB5', 'HSPB1', 'SHB', 'HERPUD1', 'RND1', 'TUBA1C', 'TMSB4X', 'ADAMTS9', 'CLIC1', 'HRAS', 'CGNL1', 'DUSP5', 'HSP90AA1', 'MMP2', 'GAB1', 'RHOC', 'EPN1', 'MMP14', 'RCN1', 'TAL1', 'RHOJ', 'ALDOA', 'GAPDH', 'FJX1', 'ENG', 'ARF6', 'KANK1', 'PBXIP1', 'APOLD1', 'PTPRZ1', 'DNAJB4', 'S1PR1', 'DNAJB9', 'ABCF2', 'SLC25A25', 'MAPK3', 'RAB11A', 'VEGFA', 'DNAJA1', 'FMNL3', 'PTPN6', 'HSPA1A']",0.644520148259771,0,0,97
134,Focal Adhesion WP306,0.15710908181144306,1.2054173052129704,2.23100434088411,"['SHC4', 'SHC3', 'FLT1', 'ITGB5', 'ITGB4', 'LAMA4', 'TNC', 'LAMC2', 'ELK1', 'THBS1', 'ACTB', 'EGFR', 'THBS4', 'ACTG1', 'CCND3', 'RELN', 'KDR', 'SPP1', 'TNR', 'ITGB8', 'HRAS', 'MAPK3', 'VAV3', 'PDGFRB', 'PDGFRA', 'JUN', 'CAV3', 'VWF', 'LAMB3', 'LAMB2', 'HGF', 'ITGA2', 'VEGFC', 'VAV1', 'VEGFA', 'FGR', 'HCK', 'COL1A2', 'PARVG', 'COL5A3', 'ITGA10', 'COL4A6', 'ITGA8', 'ITGA6', 'MYL9', 'DOCK1']",0.68705911896646,0,0,46
135,Folate Metabolism WP176,0.1606893136264717,1.4643267577399315,2.677202996222913,"['ABCA1', 'SERPINA3', 'AHCY', 'CSF1', 'GPX4', 'GPX3', 'APOA1', 'PLG', 'SOD3', 'F7', 'RFK', 'ALB', 'FOLR2']",0.6923818954787677,0,0,13
136,IL-3 signaling pathway WP286,0.1606893136264717,1.4643267577399315,2.677202996222913,"['CD86', 'LYN', 'STAT5A', 'JUN', 'SYK', 'YWHAB', 'CSF2RB', 'VAV1', 'HCK', 'INPP5D', 'PTPN6', 'HRAS', 'MAPK3']",0.6923818954787677,0,0,13
137,Metabolic reprogramming in colon cancer WP4290,0.16323130601787142,1.4867730900798175,2.6949056177858757,"['ACLY', 'LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'SUCLG2', 'PDHB', 'SLC1A5', 'ALDOB', 'GAPDH', 'IDH3A']",0.6949327701267142,0,0,12
138,Proteoglycan biosynthesis WP4784,0.16443782352515351,1.857854297097325,3.353840848354599,"['CSGALNACT1', 'XYLT1', 'B3GALT6', 'CHST14', 'B4GALT7', 'CHST3']",0.6949327701267142,0,0,6
139,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.16777555167525426,1.7340924186355442,3.0955772688226553,"['ABCC3', 'JUN', 'ABCC2', 'SRXN1', 'EPHX1', 'HMOX1', 'ABCG2']",0.6949327701267142,0,0,7
140,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.16887273198083214,1.6516071880536574,2.9375649169837272,"['ABCA1', 'ABCC3', 'ABCC2', 'VDR', 'CYP4A11', 'CYP3A4', 'ABCB11', 'PPARA']",0.6949327701267142,0,0,8
141,Benzo(a)pyrene metabolism WP696,0.16958257018450534,2.7861103212965594,4.943716868088753,"['EPHX1', 'CYP1B1', 'CYP3A4']",0.6949327701267142,0,0,3
142,COVID-19 adverse outcome pathway WP4891,0.16958257018450534,2.7861103212965594,4.943716868088753,"['IL7', 'CCL3', 'AGT']",0.6949327701267142,0,0,3
143,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.16958257018450534,2.7861103212965594,4.943716868088753,"['CEBPB', 'ALDH1L1', 'ALDH1A1']",0.6949327701267142,0,0,3
144,Exercise-induced Circadian Regulation WP410,0.18138334319089536,1.4211492980425704,2.426104463822609,"['HSPA8', 'CEBPB', 'GFRA1', 'QKI', 'AZIN1', 'HERPUD1', 'PER2', 'DNAJA1', 'CLDN5', 'TUBB3', 'STBD1', 'SUMO3', 'EIF4G2']",0.7362938417916287,0,0,13
145,Senescence and Autophagy in Cancer WP615,0.18293951173278913,1.2748283752860412,2.165423118452542,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CEBPB', 'CDKN1B', 'SERPINB2', 'GSN', 'IGFBP5', 'CDKN2A', 'HMGA1', 'CXCL1', 'CXCL14', 'THBS1', 'GABARAP', 'MMP14', 'COL3A1', 'MAP1LC3A', 'IFI16', 'IRF7', 'CCL3', 'IGFBP7', 'HRAS', 'CD44', 'SLC39A3']",0.7362938417916287,0,0,24
146,Prostaglandin Synthesis and Regulation WP98,0.18517449405634442,1.4387023209622245,2.426309150267576,"['HSD11B2', 'HPGDS', 'PTGIR', 'HPGD', 'CYP11A1', 'ANXA3', 'TBXAS1', 'S100A6', 'SOX9', 'S100A10', 'PTGDR', 'PTGES']",0.7362938417916287,0,0,12
147,Alanine and aspartate metabolism WP106,0.18906447125239062,2.1228668941979523,3.535989764870978,"['GOT1', 'GAD1', 'GAD2', 'ASPA']",0.7362938417916287,0,0,4
148,Osteoblast Signaling WP322,0.18906447125239062,2.1228668941979523,3.535989764870978,"['PDGFRB', 'PDGFRA', 'TNFRSF11B', 'PTH1R']",0.7362938417916287,0,0,4
149,Aryl Hydrocarbon Receptor Pathway WP2873,0.19542931107377076,1.520196266280003,2.4818063643944295,"['HSP90AA1', 'JUN', 'CDKN1B', 'SERPINB2', 'MYOF', 'CYP1B1', 'HES1', 'JUNB', 'EGFR']",0.7362938417916287,0,0,9
150,Osteoblast differentiation WP4787,0.19690115661203295,1.2394312434392594,2.014141980070618,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'WNT8A', 'LRP5', 'FGF2', 'PIK3R6', 'GLI3', 'PIK3R5', 'GLI2', 'FGF8', 'HEY1', 'HEY2', 'SOX9', 'WNT2', 'MAPK3', 'WNT10A', 'PRKCH', 'FZD2', 'PTCH1', 'FZD9', 'WNT9A', 'WNT16', 'SMO', 'BMPR1B', 'FGFR4', 'FGF10']",0.7362938417916287,0,0,27
151,Airway smooth muscle cell contraction WP4962,0.19697581958457383,1.857610241820768,3.018011621166594,"['RYR1', 'CD38', 'ADRB2', 'CALM1', 'CALM2']",0.7362938417916287,0,0,5
152,ERK Pathway in Huntington's Disease WP3853,0.19697581958457383,1.857610241820768,3.018011621166594,"['CASP7', 'RPS6KA5', 'ELK1', 'HRAS', 'EGFR']",0.7362938417916287,0,0,5
153,Major receptors targeted by epinephrine and norepinephrine WP4589,0.19697581958457383,1.857610241820768,3.018011621166594,"['ADCY10', 'ADCY4', 'ADRB1', 'ADRA1D', 'ADRB2']",0.7362938417916287,0,0,5
154,Mitochondrial complex III assembly WP4921,0.19697581958457383,1.857610241820768,3.018011621166594,"['UQCC3', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.7362938417916287,0,0,5
155,Striated Muscle Contraction Pathway WP383,0.19797621892554887,1.5645606042440954,2.533975437391849,"['ACTA2', 'MYOM1', 'ACTA1', 'ACTC1', 'MYL3', 'VIM', 'MYL9', 'ACTG1']",0.7362938417916287,0,0,8
156,Aflatoxin B1 metabolism WP699,0.19977938710728493,3.714326321773735,5.982077004154856,"['EPHX1', 'CYP3A4']",0.7362938417916287,0,0,2
157,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.19977938710728493,3.714326321773735,5.982077004154856,"['FMO2', 'FMO4']",0.7362938417916287,0,0,2
158,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.19977938710728493,3.714326321773735,5.982077004154856,"['CHRM1', 'CCKBR']",0.7362938417916287,0,0,2
159,Vitamin B6-dependent and responsive disorders WP4228,0.19977938710728493,3.714326321773735,5.982077004154856,"['PNPO', 'AASS']",0.7362938417916287,0,0,2
160,Circadian rhythm related genes WP3594,0.206757575450218,1.1745407221331075,1.8513208409275579,"['TPH1', 'MAGEL2', 'PHLPP1', 'AHCY', 'CHRM1', 'SUV39H1', 'OPRL1', 'RORA', 'RELB', 'CIART', 'ATOH7', 'PROKR2', 'HTR7', 'DBP', 'NFIL3', 'RPS27A', 'DRD3', 'SKP1', 'CHRNB2', 'KLF10', 'NTRK1', 'EGR1', 'NGFR', 'CPT1A', 'JUN', 'ZFHX3', 'EGR3', 'HOMER1', 'CARTPT', 'HCRTR2', 'NR2F6', 'HCRTR1', 'PER2', 'F7', 'STAR', 'ADORA2A', 'LEP', 'BHLHE40', 'CRH', 'ID3', 'UTS2', 'PPARA']",0.7572496200864235,0,0,42
161,Fas ligand pathway and stress induction of heat shock proteins WP314,0.21360070348389484,1.409577342989947,2.175889665422789,"['ACTA1', 'CASP7', 'JUN', 'CASP6', 'CASP10', 'ARHGDIB', 'HSPB1', 'CYCS', 'CFLAR', 'ACTB', 'ACTG1']",0.7679141855310576,0,0,11
162,Nephrotic syndrome WP4758,0.21360070348389484,1.409577342989947,2.175889665422789,"['CUBN', 'MYO1E', 'ANLN', 'ITGB4', 'LAMB2', 'ARHGDIA', 'COL4A5', 'GPC5', 'EMP2', 'ARHGAP24', 'PAX2']",0.7679141855310576,0,0,11
163,Vitamin A and carotenoid metabolism WP716,0.21360070348389484,1.409577342989947,2.175889665422789,"['ALDH1A3', 'CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'NPC1L1', 'ALDH1A2', 'ALDH1A1', 'LPL', 'LRAT', 'BCO1']",0.7679141855310576,0,0,11
164,Pathways in clear cell renal cell carcinoma WP4018,0.21547420066051165,1.2591016788206768,1.9326129140084358,"['PDGFRB', 'PDGFRA', 'FLT1', 'TPI1', 'PKLR', 'ENO2', 'ACACB', 'HK2', 'EGFR', 'VEGFA', 'LDHC', 'ACLY', 'LDHA', 'PKM', 'KDR', 'PGK1', 'PHGDH', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH']",0.7699261072381697,0,0,21
165,Mitochondrial CIV Assembly WP4922,0.22396268898903365,1.4539893254739762,2.175569052817545,"['COA3', 'COX7B', 'PET100', 'NDUFA4', 'SCO2', 'COX4I1', 'COX14', 'HIGD1A', 'COX7C']",0.7887347003207983,0,0,9
166,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.226287630492799,1.3419906219307416,1.994128800848503,"['JUN', 'NFATC2', 'NFKBIA', 'ZAP70', 'IL5', 'PTPRC', 'MAP3K8', 'LCP2', 'PTPN6', 'CALM1', 'CALM2', 'CARD11', 'MAPK3']",0.7887347003207983,0,0,13
167,Breast cancer pathway WP4262,0.22674169366435645,1.18151645299489,1.7533040419448598,"['SHC4', 'NOTCH2', 'NOTCH3', 'NOTCH1', 'SHC3', 'LEF1', 'LRP5', 'FGF2', 'EGFR', 'FRAT1', 'FRAT2', 'FGF8', 'HEY1', 'HEY2', 'HES1', 'WNT2', 'HRAS', 'HES5', 'SKP1', 'MAPK3', 'WNT10A', 'JUN', 'TCF7L1', 'FZD2', 'CSNK2A3', 'FZD9', 'WNT16', 'DDB2', 'FGF17', 'SFRP4', 'HEYL', 'RAD51', 'PGR', 'FGF10']",0.7887347003207983,0,0,34
168,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.22862067974844313,1.2927337701012507,1.9076756792899305,"['STAT5A', 'JUN', 'CDKN1B', 'FZD2', 'FZD9', 'TGFA', 'WNT16', 'ELK1', 'EGFR', 'ACTA1', 'TMSB4X', 'NEFL', 'PFN4', 'NEFM', 'NEFH', 'PFN2']",0.7887347003207983,0,0,16
169,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.23046995673076454,2.2287176570941143,3.2709435140363525,"['APOE', 'TLR4', 'TLR2']",0.7887347003207983,0,0,3
170,Dual hijack model of Vif in HIV infection WP3300,0.23046995673076454,2.2287176570941143,3.2709435140363525,"['CBFB', 'ELOB', 'RUNX1']",0.7887347003207983,0,0,3
171,NAD Biosynthesis II (from tryptophan) WP2485,0.23046995673076454,2.2287176570941143,3.2709435140363525,"['KYNU', 'HAAO', 'KMO']",0.7887347003207983,0,0,3
172,Unfolded protein response WP4925,0.2335121879031577,1.5298471224527386,2.2251947765674736,"['PPP1R15A', 'XBP1', 'HSPA5', 'DDIT3', 'TNFRSF10B', 'PMAIP1', 'TXNIP']",0.7887347003207983,0,0,7
173,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.23731065406692967,1.5922026180990325,2.2902007123404484,"['CD86', 'LDHA', 'VDR', 'CD80', 'HLA-DRA', 'SLC2A3']",0.7887347003207983,0,0,6
174,ACE Inhibitor Pathway WP554,0.23870167805932715,1.8573663253697383,2.6607528850047975,"['MAS1', 'ATP6AP2', 'REN', 'AGT']",0.7887347003207983,0,0,4
175,Cancer immunotherapy by CTLA4 blockade WP4582,0.23870167805932715,1.8573663253697383,2.6607528850047975,"['CD86', 'CD80', 'PTPN6', 'HLA-DRB1']",0.7887347003207983,0,0,4
176,Genes targeted by miRNAs in adipocytes WP1992,0.23870167805932715,1.8573663253697383,2.6607528850047975,"['KCNE1', 'GJA1', 'TMSB4X', 'ERG']",0.7887347003207983,0,0,4
177,Sulfation Biotransformation Reaction WP692,0.23870167805932715,1.8573663253697383,2.6607528850047975,"['SULT1C2', 'SULT1B1', 'SULT4A1', 'SULT1C4']",0.7887347003207983,0,0,4
178,Hypertrophy Model WP516,0.23958153013157354,1.688607267554636,2.412785916562929,"['NR4A3', 'MSTN', 'WDR1', 'IL1R1', 'VEGFA']",0.7887347003207983,0,0,5
179,AGE/RAGE pathway WP2324,0.2499280079224141,1.2651316428640824,1.754209232864445,"['STAT5A', 'JUN', 'NCF1', 'MMP2', 'MSN', 'INHBB', 'FOXO4', 'FOXO1', 'EGFR', 'NFKBIA', 'LGALS3', 'MMP14', 'ALPL', 'CYCS', 'EZR', 'MAPK3']",0.8182000706286853,0,0,16
180,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.2539396570571373,1.3932996297351181,1.9097381349615303,"['YAP1', 'FYB1', 'LATS2', 'RAB13', 'LPL', 'FOXO4', 'FOXO1', 'TEAD2', 'TEAD3']",0.8267146613082358,0,0,9
181,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.27518674285825495,1.2711644380412108,1.6401902711132776,"['VAV3', 'BEX3', 'CDKN1B', 'HSPA5', 'HSPB1', 'TNFRSF10B', 'YBX3', 'THBS1', 'SOCS3', 'CASP7', 'ERBB3', 'APOE', 'VIM']",0.8650504443006507,0,0,13
182,Ferroptosis WP4313,0.2756322104038208,1.3269230769230769,1.7099896775389845,"['PRNP', 'TF', 'MAP1LC3A', 'GPX4', 'PCBP1', 'ALOX15', 'HMOX1', 'CYBB', 'SLC7A11', 'CP']",0.8650504443006507,0,0,10
183,Oxidative Damage WP3941,0.2756322104038208,1.3269230769230769,1.7099896775389845,"['C1QB', 'C1QA', 'CDKN1B', 'C1R', 'C5AR1', 'C3AR1', 'CYCS', 'TNFRSF1B', 'NFKBIE', 'C1QC']",0.8650504443006507,0,0,10
184,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.2768716977288367,1.4859419464997154,1.9082482305093036,"['CD86', 'IL4R', 'CD80', 'TLR7', 'TLR4', 'TGFBR2']",0.8650504443006507,0,0,6
185,Corticotropin-releasing hormone signaling pathway WP2355,0.2789776557586351,1.1988018433179723,1.5304187096239088,"['GNAZ', 'HSP90AA1', 'JUP', 'HSD3B1', 'ELK1', 'TBX19', 'FOSL2', 'NFKBIA', 'CRHBP', 'NR4A1', 'GJA1', 'STAR', 'CYP11A1', 'CRH', 'PLCG2', 'FOSB', 'JUNB', 'TLR4', 'RAPGEF3', 'MAPK3']",0.8650504443006507,0,0,20
186,miR-509-3p alteration of YAP1/ECM axis WP3967,0.28434071185462706,1.5477714556661926,1.9464496314820794,"['YAP1', 'COL3A1', 'PBX3', 'TEAD2', 'TEAD3']",0.8650504443006507,0,0,5
187,Regulatory circuits of the STAT3 signaling pathway WP4538,0.28508274889013635,1.2148323415094755,1.5245851822085468,"['PDGFRB', 'PDGFRA', 'DUSP2', 'CSF3R', 'IL10RA', 'LIFR', 'CSF2RB', 'OSMR', 'CSF2RA', 'MAPK15', 'EGFR', 'SOCS3', 'PTPRC', 'STMN1', 'IL21R', 'F2RL2', 'MAPK3']",0.8650504443006507,0,0,17
188,MED and Pseudoachondroplasia genes WP4789,0.28784565518112154,2.476028046238393,3.083474141188873,"['COL9A1', 'COL9A2']",0.8650504443006507,0,0,2
189,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.28784565518112154,2.476028046238393,3.083474141188873,"['EGFR', 'MAPK3']",0.8650504443006507,0,0,2
190,Cytoplasmic Ribosomal Proteins WP477,0.2898817725730397,1.182428745875445,1.4641803740835633,"['RPL41', 'RPL3', 'RPS7', 'RPL35A', 'RPSA', 'RPL10A', 'RPL7', 'RPS15', 'RPS26', 'RPL7A', 'RPS25', 'RPL18A', 'RPL14', 'RPL38', 'RPL26', 'RPL15', 'FAU', 'RPS27A', 'RPL18', 'RPL17', 'RPS21']",0.8650504443006507,0,0,21
191,Osteoclast Signaling WP12,0.290847152326301,1.6508658829477942,2.038749037795187,"['ATP6V1G1', 'GPR68', 'SPP1', 'TNFRSF11B']",0.8650504443006507,0,0,4
192,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.29443336372952705,1.8571225476258175,2.2707085130181466,"['CYP4A11', 'PPARA', 'CYP2C18']",0.8650504443006507,0,0,3
193,FOXP3 in COVID-19 WP5063,0.29443336372952705,1.8571225476258175,2.2707085130181466,"['CD86', 'STAT5A', 'CD80']",0.8650504443006507,0,0,3
194,Leptin and adiponectin WP3934,0.29443336372952705,1.8571225476258175,2.2707085130181466,"['CPT1A', 'LEP', 'LEPR']",0.8650504443006507,0,0,3
195,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.29443336372952705,1.8571225476258175,2.2707085130181466,"['LFNG', 'NOTCH1', 'TBX6']",0.8650504443006507,0,0,3
196,Trans-sulfuration pathway WP2333,0.29443336372952705,1.8571225476258175,2.2707085130181466,"['AHCY', 'GOT1', 'MAT2B']",0.8650504443006507,0,0,3
197,Vitamin B12 Disorders WP4271,0.29443336372952705,1.8571225476258175,2.2707085130181466,"['CUBN', 'TCN2', 'TCN1']",0.8650504443006507,0,0,3
198,Vitamin D Metabolism WP1531,0.29443336372952705,1.8571225476258175,2.2707085130181466,"['CYP27A1', 'VDR', 'GC']",0.8650504443006507,0,0,3
199,Endothelin Pathways WP2197,0.29523905948827667,1.3509008076206255,1.6480582957177319,"['CNN1', 'ADCY10', 'PTGIR', 'CALCRL', 'ATP2A2', 'ADRB1', 'CALM1', 'CALM2']",0.8650504443006507,0,0,8
200,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.29523905948827667,1.3509008076206255,1.6480582957177319,"['FKBP10', 'ADAMTS2', 'COL1A2', 'CREB3L1', 'SERPINF1', 'LRP5', 'SERPINH1', 'TNFRSF11B']",0.8650504443006507,0,0,8
201,22q11.2 copy number variation syndrome WP4657,0.3008249740518746,1.1583107967547326,1.3913938153200989,"['TBX1', 'RANBP1', 'FOXC1', 'OAT', 'VWF', 'SERPIND1', 'LRRC74B', 'RTN4', 'EGFR', 'SLC7A4', 'ACTA2', 'CLDN5', 'CYP26B1', 'FGF8', 'MRPL40', 'RELN', 'ACTC1', 'THAP7', 'ALDH1A2', 'RCC1', 'HES1', 'PRODH', 'RAN', 'FGF10']",0.8770320139024801,0,0,24
202,Hedgehog Signaling Pathway WP4249,0.30555761943131693,1.2810688672757637,1.518856913425866,"['EVC2', 'EVC', 'SMO', 'SUFU', 'PTCH1', 'BOC', 'LRP2', 'GLI1', 'GLI3', 'GLI2']",0.8784839258430995,0,0,10
203,IL-5 signaling pathway WP127,0.30555761943131693,1.2810688672757637,1.518856913425866,"['LYN', 'STAT5A', 'GSK3A', 'SPRED1', 'JUN', 'SYK', 'BTK', 'CSF2RB', 'ELK1', 'MAPK3']",0.8784839258430995,0,0,10
204,7-oxo-C and 7beta-HC pathways WP5064,0.3060891707115447,1.368600835992629,1.620257531716737,"['CYP27A1', 'HSD11B2', 'DBP', 'ACOT11', 'THEM5', 'ACOT6', 'ACOT4']",0.8784839258430995,0,0,7
205,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.3073194621123471,1.1918194108553855,1.4061889639915655,"['TCF7L1', 'ITGB5', 'JUP', 'ITGB4', 'ITGA2', 'LEF1', 'ATP2A2', 'ACTB', 'ACTG1', 'GJA1', 'ITGA10', 'ITGA8', 'ITGB8', 'ITGA6', 'CACNG1', 'CACNG4', 'CACNG5']",0.8784839258430995,0,0,17
206,"GPCRs, Class B Secretin-like WP334",0.3177827464954166,1.392963858850313,1.5968761005495131,"['ADGRE1', 'ADGRE2', 'CALCRL', 'ADGRG2', 'GIPR', 'PTH1R']",0.8996168572285708,0,0,6
207,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.3177827464954166,1.392963858850313,1.5968761005495131,"['GSK3A', 'BCL2L10', 'ITGB4', 'ITGA6', 'BCL2L14', 'BCL2L2']",0.8996168572285708,0,0,6
208,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.3197384098065331,1.1611607142857143,1.3240159276362689,"['TCF7L1', 'WNT10A', 'JUN', 'FZD2', 'CSNK2A3', 'SERPINF1', 'LEF1', 'LRP5', 'FZD9', 'WNT16', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'CCND3', 'FRAT2', 'SFRP2', 'WIF1', 'WNT2']",0.9008014814741752,0,0,20
209,Nanomaterial induced apoptosis WP2507,0.33045719951809494,1.4286026917605865,1.5818605174614528,"['CASP7', 'ENDOG', 'CASP6', 'CYCS', 'CFLAR']",0.9221329472266839,0,0,5
210,Nucleotide metabolism WP404,0.33045719951809494,1.4286026917605865,1.5818605174614528,"['PRPS1', 'RRM2', 'POLD1', 'NME2', 'OAZ1']",0.9221329472266839,0,0,5
211,Apoptosis WP254,0.34137644036753445,1.1530258571456704,1.2392370007789397,"['JUN', 'CRADD', 'CDKN2A', 'TNFRSF10B', 'CFLAR', 'TNFRSF1B', 'NFKBIA', 'CASP7', 'CASP6', 'CASP10', 'CASP4', 'CASP1', 'TNFSF10', 'IRF7', 'PMAIP1', 'CYCS', 'NFKBIE', 'BCL2L2']",0.9426857656260647,0,0,18
212,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.3439286965923805,1.3000711642470824,1.3875931516635032,"['TGFBR3', 'HGF', 'TGFA', 'HRAS', 'EGFR', 'PIK3R5', 'TGFBR2']",0.9426857656260647,0,0,7
213,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.3439286965923805,1.3000711642470824,1.3875931516635032,"['EGLN2', 'MMP2', 'CFLAR', 'SELE', 'BCL2L2', 'RELB', 'VEGFA']",0.9426857656260647,0,0,7
214,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.3442572591194161,1.485665529010239,1.5842632889661692,"['TERT', 'CDH1', 'ALPL', 'ITGA6']",0.9426857656260647,0,0,4
215,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.35284766374036614,1.2018255578093306,1.2519643532088354,"['CCNA2', 'PDGFRA', 'HSP90AA1', 'JUN', 'CDKN2A', 'MMP2', 'TNFSF10', 'CFLAR', 'ELK1', 'JUNB', 'EGFR']",0.9532354689404126,0,0,11
216,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.3592273187231562,1.5916974694341768,1.629579695861794,"['SOCS3', 'CDH1', 'CHI3L1']",0.9532354689404126,0,0,3
217,Neuroinflammation WP4919,0.3592273187231562,1.5916974694341768,1.629579695861794,"['NFKBIA', 'JUN', 'TLR4']",0.9532354689404126,0,0,3
218,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.3592273187231562,1.5916974694341768,1.629579695861794,"['KLF4', 'ELK1', 'MEF2D']",0.9532354689404126,0,0,3
219,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.35949665296216926,1.3109243697478992,1.3411417167321456,"['FSHR', 'CGA', 'SGK1', 'CYP19A1', 'FOXO1', 'MAPK3']",0.9532354689404126,0,0,6
220,"Relationship between inflammation, COX-2 and EGFR WP4483",0.35949665296216926,1.3109243697478992,1.3411417167321456,"['PTGES2', 'CYP19A1', 'HRAS', 'EGFR', 'MAPK3', 'PLA1A']",0.9532354689404126,0,0,6
221,Zinc homeostasis WP3529,0.35949665296216926,1.3109243697478992,1.3411417167321456,"['SLC30A3', 'SLC30A2', 'SLC39A11', 'SLC39A7', 'SLC39A12', 'SLC39A3']",0.9532354689404126,0,0,6
222,Alpha 6 Beta 4 signaling pathway WP244,0.3652864130302713,1.2381359149582385,1.2468939187255927,"['LAMB3', 'ITGB4', 'LAMB2', 'GAB1', 'LAMC2', 'ITGA6', 'HRAS', 'MAPK3']",0.9557801239235135,0,0,8
223,Melatonin metabolism and effects WP3298,0.3652864130302713,1.2381359149582385,1.2468939187255927,"['PER2', 'CYP1B1', 'ADRB1', 'APOE', 'CYP2C19', 'CALM1', 'CALM2', 'FOXO1']",0.9557801239235135,0,0,8
224,Oncostatin M Signaling Pathway WP2374,0.3669260725942375,1.1557076757304938,1.15870660804683,"['EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'LIFR', 'OSMR', 'VEGFA', 'NFKBIA', 'SOCS3', 'CASP7', 'CDK2', 'JUNB', 'HRAS', 'MAPK3']",0.9557801239235135,0,0,14
225,Development of ureteric collection system WP5053,0.36737253592973657,1.1982354562999724,1.1998876570386223,"['FOXC1', 'SMO', 'ITGA8', 'GFRA1', 'GLI1', 'ETV4', 'GLI3', 'PAX2', 'FREM2', 'GLI2']",0.9557801239235135,0,0,10
226,Hfe effect on hepcidin production WP3924,0.3745763857063832,1.856878908470722,1.8233799395790748,"['HFE', 'HAMP']",0.9557801239235135,0,0,2
227,Metabolism of alpha-linolenic acid WP4586,0.3745763857063832,1.856878908470722,1.8233799395790748,"['ALOX5', 'ALOX15']",0.9557801239235135,0,0,2
228,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.3745763857063832,1.856878908470722,1.8233799395790748,"['SIX4', 'CTDSP1']",0.9557801239235135,0,0,2
229,GDNF/RET signaling axis WP4830,0.377172821604921,1.3264580369843528,1.2933652751345812,"['FOXC1', 'EYA1', 'GFRA1', 'PAX2', 'GLI3']",0.9557801239235135,0,0,5
230,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.377172821604921,1.3264580369843528,1.2933652751345812,"['EGR1', 'HTR7', 'RPS6KA5', 'ELK1', 'MAPK3']",0.9557801239235135,0,0,5
231,Transcription factor regulation in adipogenesis WP3599,0.377172821604921,1.3264580369843528,1.2933652751345812,"['CEBPA', 'CEBPB', 'CEBPD', 'LEP', 'FOXO1']",0.9557801239235135,0,0,5
232,Prader-Willi and Angelman Syndrome WP3998,0.3809688998118451,1.149748122802015,1.1095500942739775,"['PCSK1', 'MAGEL2', 'DLX5', 'CDKN2A', 'ATP10A', 'TYR', 'KISS1', 'GABRR2', 'NDN', 'MKRN3', 'MSX1', 'CGA', 'GABRD']",0.9557801239235135,0,0,13
233,IL17 signaling pathway WP2112,0.38226009148345846,1.2380681279058734,1.1905932099427823,"['CEBPB', 'CEBPD', 'IL17RE', 'IL17RD', 'IL17RB', 'MAPK3', 'IL17RA']",0.9557801239235135,0,0,7
234,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.38226009148345846,1.2380681279058734,1.1905932099427823,"['CEBPA', 'TTC9', 'CEBPB', 'ERBB3', 'PGR', 'PRLR', 'EGFR']",0.9557801239235135,0,0,7
235,Bladder cancer WP2828,0.38329066403076056,1.1938906294502991,1.1448953443085514,"['RPS6KA5', 'CDH1', 'CDKN2A', 'DAPK2', 'MMP2', 'THBS1', 'HRAS', 'EGFR', 'VEGFA']",0.9557801239235135,0,0,9
236,Endoderm differentiation WP2853,0.38923703221667955,1.0835600420007636,1.0224112636858602,"['NOTCH1', 'ONECUT1', 'LEF1', 'WNT8A', 'SOX21', 'FOXO1', 'GLI2', 'SOX2', 'HHEX', 'ZIC3', 'TCEAL2', 'VAV3', 'DUSP4', 'DUSP5', 'ZNF462', 'DUSP2', 'TCF7L1', 'SLC2A12', 'PBX3', 'ZIC5', 'DKK1', 'ZFHX4', 'BMP7', 'GRHL2', 'DAB2', 'RGS10', 'RAB38', 'NODAL']",0.9664953427075179,0,0,28
237,Wnt signaling WP428,0.396908124051375,1.0872634927722276,1.0046863204619692,"['WNT10A', 'JUN', 'TCF7L1', 'FZD2', 'CSNK2A3', 'SERPINF1', 'LEF1', 'FZD9', 'LRP5', 'NFATC2', 'NFATC1', 'WNT16', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'CCND3', 'FRAT2', 'SFRP2', 'DAAM2', 'WIF1', 'GPC4', 'WNT2']",0.9672990882892798,0,0,24
238,Cell Differentiation - Index expanded WP2023,0.3978141301667516,1.35050160306133,1.2448523926067931,"['SOX2', 'PAX7', 'KLF4', 'MEF2D']",0.9672990882892798,0,0,4
239,Galanin receptor pathway WP4970,0.3978141301667516,1.35050160306133,1.2448523926067931,"['YAP1', 'CDKN1B', 'UCP1', 'VEGFA']",0.9672990882892798,0,0,4
240,ID signaling pathway WP53,0.3978141301667516,1.35050160306133,1.2448523926067931,"['CDK2', 'ID3', 'ELK1', 'PAX2']",0.9672990882892798,0,0,4
241,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.3978141301667516,1.35050160306133,1.2448523926067931,"['ABCA1', 'HMGCS1', 'HMGCR', 'PPARA']",0.9672990882892798,0,0,4
242,Angiogenesis WP1539,0.4014914623482169,1.2380003794346424,1.1297607808995502,"['PDGFRA', 'FLT1', 'TIMP2', 'KDR', 'FGF2', 'VEGFA']",0.9722065989093187,0,0,6
243,Chemokine signaling pathway WP3929,0.40315565789314123,1.0716056865770334,0.9734814797393111,"['SHC4', 'CX3CR1', 'SHC3', 'NCF1', 'CXCR5', 'ADCY4', 'CXCR4', 'PRKX', 'CXCL13', 'CXCL14', 'CXCL5', 'CX3CL1', 'CXCL16', 'PIK3R5', 'PREX1', 'GNG10', 'GNG3', 'CCL3', 'HRAS', 'MAPK3', 'LYN', 'CCR1', 'VAV3', 'GNG12', 'GNG11', 'VAV1', 'NFKBIA', 'FGR', 'HCK', 'PARD3']",0.972218993931608,0,0,30
244,Netrin-UNC5B signaling pathway WP4747,0.41249179166765837,1.1348833159177987,1.004983405363676,"['YAP1', 'CDH5', 'ROBO4', 'JUN', 'ITGB4', 'INPP5D', 'KDR', 'ALPL', 'PLEKHH1', 'SELE', 'MAPK3']",0.9854881255673202,0,0,11
245,Pathways Regulating Hippo Signaling WP4540,0.41369617864361,1.0833928741545202,0.9562279482533065,"['PDGFRB', 'NTRK1', 'PDGFRA', 'CSF1R', 'NGFR', 'TCF7L1', 'PRKCH', 'FLT1', 'LEF1', 'EGFR', 'CDH5', 'LATS2', 'CDH1', 'PRKAR1A', 'CDH20', 'KDR', 'FGFR4', 'TEAD2', 'EPHA2', 'TEAD3', 'CDH19']",0.9854881255673202,0,0,21
246,Neural Crest Cell Migration during Development WP4564,0.41670189830263243,1.1526335949086124,1.0089972200852695,"['NGFR', 'ARF1', 'JUN', 'MMP2', 'PIK3R6', 'EPHB4', 'F2RL2', 'PIK3R5', 'EPHB3']",0.9854881255673202,0,0,9
247,Cell migration and invasion through p75NTR WP4561,0.420696904671616,1.1817017312320472,1.0231677537286334,"['NGFR', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'MMP2', 'PARD3']",0.9854881255673202,0,0,7
248,miRNAs involvement in the immune response in sepsis WP4329,0.420696904671616,1.1817017312320472,1.0231677537286334,"['NFKBIA', 'CCL3', 'IRF7', 'TLR7', 'TLR4', 'ELANE', 'RELB']",0.9854881255673202,0,0,7
249,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4237935284009636,1.2379326695116168,1.0627762189231973,"['BCL6', 'H2AFZ', 'DUSP6', 'HIST1H3E', 'MAPK3']",0.9854881255673202,0,0,5
250,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.4237935284009636,1.2379326695116168,1.0627762189231973,"['B3GALNT1', 'UGT8', 'B3GALT1', 'B4GALNT1', 'ST6GALNAC3']",0.9854881255673202,0,0,5
251,One-carbon metabolism WP241,0.4237935284009636,1.2379326695116168,1.0627762189231973,"['ALDH1L1', 'AHCY', 'FOLH1', 'TCN2', 'MAT2B']",0.9854881255673202,0,0,5
252,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.4237935284009636,1.2379326695116168,1.0627762189231973,"['GSDMD', 'NFKBIA', 'FCGR2A', 'CGAS', 'NFKBIE']",0.9854881255673202,0,0,5
253,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.42704003546611424,1.0766045548654244,0.9160586031944995,"['COX7B', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'COX4I1', 'UCP1', 'ATP5MC3', 'UQCR11', 'UQCR10', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5F1B', 'UCP2', 'UQCRFS1', 'SLC25A5', 'SLC25A4', 'ATP5MF', 'SLC25A6']",0.9891124932140037,0,0,20
254,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.4295419181278077,1.0923890240832423,0.9231079910733864,"['CDKN1B', 'CR1', 'KIRREL2', 'NOTCH1', 'ITGB4', 'LAMB2', 'CD80', 'LRP5', 'DKK1', 'PAX2', 'MYO1E', 'COL4A5', 'VIM', 'UTRN', 'TLR4']",0.9909904095389578,0,0,15
255,Photodynamic therapy-induced unfolded protein response WP3613,0.4432846606098552,1.1727525986280443,0.9540848321873763,"['PPP1R15A', 'NARS', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9']",0.9959389319629467,0,0,6
256,G1 to S cell cycle control WP45,0.4457045154472215,1.0832263738353298,0.8753542230699419,"['CDKN2D', 'CDKN1B', 'CDKN2A', 'PRIM1', 'MYT1', 'CREB3', 'CCND3', 'TFDP2', 'CREB3L1', 'RPA3', 'CDK2', 'MCM4', 'MCM5', 'POLE']",0.9959389319629467,0,0,14
257,FOXA2 pathway WP5066,0.4505583093575916,1.237864998103906,0.986909876221451,"['ABCC3', 'SLCO1B1', 'ABCC2', 'FOXO1']",0.9959389319629467,0,0,4
258,MAPK pathway in congenital thyroid cancer WP4928,0.4505583093575916,1.237864998103906,0.986909876221451,"['GAREM2', 'JUN', 'ELK1', 'MAPK3']",0.9959389319629467,0,0,4
259,NOTCH1 regulation of endothelial cell calcification WP3413,0.4505583093575916,1.237864998103906,0.986909876221451,"['NOTCH1', 'LPAR1', 'ALPL', 'VEGFA']",0.9959389319629467,0,0,4
260,Serotonin and anxiety WP3947,0.4505583093575916,1.237864998103906,0.986909876221451,"['GABRA1', 'ARC', 'PLEK', 'CRH']",0.9959389319629467,0,0,4
261,LDLRAD4 and what we know about it WP4904,0.45657387572823316,1.4853894258101195,1.1645523822351358,"['NEDD4', 'TGFBR2']",0.9959389319629467,0,0,2
262,Mevalonate pathway WP3963,0.45657387572823316,1.4853894258101195,1.1645523822351358,"['HMGCS1', 'HMGCR']",0.9959389319629467,0,0,2
263,Nanomaterial-induced inflammasome activation WP3890,0.45657387572823316,1.4853894258101195,1.1645523822351358,"['CASP1', 'TLR4']",0.9959389319629467,0,0,2
264,Peroxiredoxin 2 induced ovarian failure WP4873,0.45657387572823316,1.4853894258101195,1.1645523822351358,"['STAR', 'CYP11A1']",0.9959389319629467,0,0,2
265,"Phase I biotransformations, non P450 WP136",0.45657387572823316,1.4853894258101195,1.1645523822351358,"['PON3', 'PON2']",0.9959389319629467,0,0,2
266,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.45657387572823316,1.4853894258101195,1.1645523822351358,"['NFKBIA', 'MUC1']",0.9959389319629467,0,0,2
267,SARS-CoV-2 and COVID-19 Pathway WP4846,0.45657387572823316,1.4853894258101195,1.1645523822351358,"['NRP1', 'TLR7']",0.9959389319629467,0,0,2
268,The alternative pathway of fetal androgen synthesis WP4524,0.45657387572823316,1.4853894258101195,1.1645523822351358,"['STAR', 'CYP11A1']",0.9959389319629467,0,0,2
269,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.4588797126791734,1.130236760355945,0.8804173274188869,"['PTGIR', 'HPGD', 'CYP4A11', 'TBXAS1', 'PLA2G5', 'PTGDR', 'PTGES']",0.9959389319629467,0,0,7
270,GABA receptor Signaling WP4159,0.4588797126791734,1.130236760355945,0.8804173274188869,"['GABRA1', 'SLC32A1', 'GAD1', 'GAD2', 'GABRE', 'GABRD', 'AP2M1']",0.9959389319629467,0,0,7
271,IL1 and megakaryocytes in obesity WP2865,0.4697065813685724,1.160472972972973,0.8769080067056393,"['TLR1', 'IL1R1', 'TIMP2', 'S100A9', 'TLR2']",0.9996745192888725,0,0,5
272,Matrix Metalloproteinases WP129,0.4697065813685724,1.160472972972973,0.8769080067056393,"['MMP14', 'MMP2', 'TIMP2', 'MMP19', 'MMP21']",0.9996745192888725,0,0,5
273,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.47189777744071704,1.1003121572597654,0.8263266069605122,"['IFITM3', 'BST2', 'JUN', 'IFITM2', 'IFI27', 'DDIT3', 'JUNB', 'MAPK3']",0.9996745192888725,0,0,8
274,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.47189777744071704,1.1003121572597654,0.8263266069605122,"['LDHA', 'PKM', 'IGFBP2', 'PGK1', 'TGFA', 'PMAIP1', 'SLC2A3', 'VEGFA']",0.9996745192888725,0,0,8
275,Synaptic Vesicle Pathway WP2267,0.47224096294280593,1.0749876258043227,0.8065265681900459,"['NSF', 'RAB3A', 'SLC32A1', 'SLC1A3', 'SLC17A6', 'ATP1A2', 'SYN3', 'SLC25A4', 'CPLX1', 'SLC18A2', 'AP2M1']",0.9996745192888725,0,0,11
276,Glycogen Synthesis and Degradation WP500,0.48309410100850264,1.0781047583171783,0.7843684522869024,"['GYS2', 'GSK3A', 'HKDC1', 'PYGM', 'PHKA1', 'CALM3', 'CALM1', 'CALM2', 'HK2']",0.9996745192888725,0,0,9
277,Cannabinoid receptor signaling WP3869,0.4844432898341607,1.1140295959021058,0.807398412104807,"['CNR2', 'ADORA2A', 'PRKAR1A', 'CYP2C19', 'CYP3A4', 'MAPK3']",0.9996745192888725,0,0,6
278,Ethanol effects on histone modifications WP3996,0.4844432898341607,1.1140295959021058,0.807398412104807,"['KAT2B', 'ALDH1A3', 'AHCY', 'ADH1B', 'ALDH1A2', 'ALDH1A1']",0.9996745192888725,0,0,6
279,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.4844838967202044,1.237797365178656,0.8969959597669451,"['SST', 'DKK1', 'FOXO1']",0.9996745192888725,0,0,3
280,Iron metabolism in placenta WP2007,0.4844838967202044,1.237797365178656,0.8969959597669451,"['TF', 'HEPHL1', 'HAMP']",0.9996745192888725,0,0,3
281,LTF danger signal response pathway WP4478,0.4844838967202044,1.237797365178656,0.8969959597669451,"['CD14', 'TLR4', 'TLR2']",0.9996745192888725,0,0,3
282,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.4844838967202044,1.237797365178656,0.8969959597669451,"['STAT5A', 'PGR', 'VIM']",0.9996745192888725,0,0,3
283,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.4844838967202044,1.237797365178656,0.8969959597669451,"['JUN', 'RYR3', 'MAPK3']",0.9996745192888725,0,0,3
284,Serotonin and anxiety-related events WP3944,0.4844838967202044,1.237797365178656,0.8969959597669451,"['ARC', 'PLEK', 'CRH']",0.9996745192888725,0,0,3
285,Tumor suppressor activity of SMARCB1 WP4204,0.4964825950245573,1.0830605370528512,0.7583664085791066,"['SMO', 'CDKN2A', 'PTCH1', 'DPF3', 'GLI1', 'GLI3', 'GLI2']",0.9999956487937446,0,0,7
286,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.4967657901347745,1.0187162181013907,0.7127311625775025,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'EIF5A2', 'WNT8A', 'LRP5', 'CLDN2', 'FOXM1', 'CLDN20', 'CDH1', 'WNT2', 'HRAS', 'MEF2D', 'MAPK3', 'WNT10A', 'FZD2', 'JUP', 'GDF15', 'MMP2', 'FZD9', 'WNT9A', 'WNT16', 'TGFBR2', 'CLDN5', 'CLDN10', 'LATS2', 'CLDN9', 'CTDSP1', 'COL4A6', 'COL4A5', 'STRAP']",0.9999956487937446,0,0,31
287,15q13.3 copy number variation syndrome WP4942,0.5017021605539562,1.1425571016014702,0.7880772081348157,"['TRPM1', 'KAT2B', 'SERPINH1', 'CHRFAM7A']",0.9999956487937446,0,0,4
288,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.5017021605539562,1.1425571016014702,0.7880772081348157,"['CDH1', 'TNC', 'VIM', 'MAPK3']",0.9999956487937446,0,0,4
289,IL-4 signaling pathway WP395,0.5017413564289711,1.0473434611365646,0.7223219076824356,"['STAT5A', 'NFKBIA', 'CEBPA', 'SOCS3', 'CEBPB', 'IL4R', 'NFIL3', 'INPP5D', 'PTPN6', 'ELK1', 'MAPK3']",0.9999956487937446,0,0,11
290,Nuclear receptors WP170,0.5067105089724867,1.0609339407744875,0.7212392596340678,"['NR4A1', 'VDR', 'RORA', 'NR0B1', 'PGR', 'NR2F2', 'PPARA', 'NR2F6']",0.9999956487937446,0,0,8
291,Oxysterols derived from cholesterol WP4545,0.5067105089724867,1.0609339407744875,0.7212392596340678,"['CYP39A1', 'CYP27A1', 'DBP', 'ACOT11', 'THEM5', 'CYP3A4', 'ACOT6', 'ACOT4']",0.9999956487937446,0,0,8
292,Nicotine Metabolism WP1600,0.511071048462452,1.856635407786303,1.24626031697589,['CYP2A6'],0.9999956487937446,0,0,1
293,Acute viral myocarditis WP4298,0.5120398544230264,1.024326877657062,0.6856360803736743,"['ENDOG', 'CD80', 'ITGB2', 'CXCR4', 'NOD2', 'AIF1', 'ACTB', 'CASP7', 'CASP6', 'CASP1', 'CYCS', 'TLR5', 'TLR4', 'TLR3', 'EIF4G2', 'MAPK3']",0.9999956487937446,0,0,16
294,Aryl Hydrocarbon Receptor Netpath WP2586,0.5156407765870499,1.0443338792366847,0.6917092452771921,"['HPGDS', 'HSP90AA1', 'CDKN1B', 'CDK2', 'LPL', 'CYP1B1', 'HRAS', 'EGFR', 'VEGFA']",0.9999956487937446,0,0,9
295,DNA Replication WP466,0.5156407765870499,1.0443338792366847,0.6917092452771921,"['CDT1', 'PRIM1', 'POLD1', 'RPA3', 'GMNN', 'CDK2', 'MCM4', 'MCM5', 'POLE']",0.9999956487937446,0,0,9
296,IL-6 signaling pathway WP364,0.5156407765870499,1.0443338792366847,0.6917092452771921,"['SOCS3', 'HCK', 'GAB1', 'VIP', 'JUNB', 'AGT', 'VAV1', 'MAPK3', 'NR2F6']",0.9999956487937446,0,0,9
297,Neural Crest Cell Migration in Cancer WP4565,0.5156407765870499,1.0443338792366847,0.6917092452771921,"['NGFR', 'ARF1', 'JUN', 'MMP2', 'PIK3R6', 'EPHB4', 'F2RL2', 'PIK3R5', 'EPHB3']",0.9999956487937446,0,0,9
298,Monoamine Transport WP727,0.5245902964253514,1.0608992601024474,0.6844261179436776,"['ADORA2A', 'IL1R1', 'TGFB1I1', 'TNFRSF11B', 'DBH', 'AGT']",0.9999956487937446,0,0,6
299,Canonical NF-KB pathway WP4562,0.5319418041847898,1.237729770703051,0.7812812541252921,"['NFKBIA', 'NFKBIE']",0.9999956487937446,0,0,2
300,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.5319418041847898,1.237729770703051,0.7812812541252921,"['CBFB', 'ELOB']",0.9999956487937446,0,0,2
301,Neovascularisation processes WP4331,0.5407573456551513,1.0242714633571597,0.6297063526637158,"['ACVRL1', 'NOTCH3', 'NOTCH1', 'KDR', 'CXCR4', 'EPHB4', 'RELB', 'MAPK3']",0.9999956487937446,0,0,8
302,Vitamin D-sensitive calcium signaling in depression WP4698,0.5407573456551513,1.0242714633571597,0.6297063526637158,"['CYP27A1', 'TPH1', 'CHRM1', 'CALB1', 'GPX4', 'VDR', 'ITPR2', 'PVALB']",0.9999956487937446,0,0,8
303,Cysteine and methionine catabolism WP4504,0.5425748859781232,1.1139323286892238,0.6810907129560358,"['AHCY', 'GOT1', 'SQOR']",0.9999956487937446,0,0,3
304,Ganglio Sphingolipid Metabolism WP1423,0.5425748859781232,1.1139323286892238,0.6810907129560358,"['B3GALT1', 'B4GALNT1', 'FUT1']",0.9999956487937446,0,0,3
305,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5491465910390617,0.9995941024178332,0.5991465675772432,"['HSPA8', 'HSPA5', 'TUBB', 'TUBB4B', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBA1C', 'TUBB2A', 'TUBB3', 'CASP1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.9999956487937446,0,0,14
306,Apoptosis Modulation by HSP70 WP384,0.5506292637809638,1.0608646188850968,0.6330110636218962,"['CASP7', 'CASP6', 'CYCS', 'HSPA1A']",0.9999956487937446,0,0,4
307,Nicotine Activity on Dopaminergic Neurons WP1602,0.5506292637809638,1.0608646188850968,0.6330110636218962,"['CHRNB2', 'DRD3', 'SLC18A2', 'KCNK3']",0.9999956487937446,0,0,4
308,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.5506292637809638,1.0608646188850968,0.6330110636218962,"['MDH2', 'IDH3B', 'SUCLG2', 'IDH3A']",0.9999956487937446,0,0,4
309,Transcription co-factors SKI and SKIL protein partners WP4533,0.5506292637809638,1.0608646188850968,0.6330110636218962,"['LATS2', 'MERTK', 'TEAD2', 'TEAD3']",0.9999956487937446,0,0,4
310,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.557415956044303,1.0313734787418998,0.6027795654330853,"['TGFBR3', 'LTBP1', 'MAPK3', 'TGFBR2', 'ENG']",0.9999956487937446,0,0,5
311,RAS and bradykinin pathways in COVID-19 WP4969,0.557415956044303,1.0313734787418998,0.6027795654330853,"['VDR', 'F12', 'REN', 'CYP3A4', 'AGT']",0.9999956487937446,0,0,5
312,Oxidative Stress WP408,0.5634076028174115,1.0125989548300305,0.5809806037407211,"['GPX3', 'HMOX1', 'CYBB', 'XDH', 'JUNB', 'SOD3']",0.9999956487937446,0,0,6
313,ESC Pluripotency Pathways WP3931,0.5653085381904971,0.9840115177691899,0.5612640433543927,"['PDGFRB', 'PDGFRA', 'WNT10A', 'JUN', 'FZD2', 'FZD9', 'GAB1', 'LRP5', 'LIFR', 'SMAD6', 'WNT16', 'FGF2', 'ELK1', 'EGFR', 'FGF17', 'FGF8', 'SELENOP', 'BMPR1B', 'FGFR4', 'WNT2', 'HRAS', 'FGF10']",0.9999956487937446,0,0,22
314,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5688367565018372,0.9995949112089163,0.5639332458315021,"['IFIH1', 'NFKBIA', 'JUN', 'OAS1', 'OAS2', 'OAS3', 'TLR7']",0.9999956487937446,0,0,7
315,Type 2 papillary renal cell carcinoma WP4241,0.5688367565018372,0.9995949112089163,0.5639332458315021,"['EGLN3', 'EGLN2', 'EPAS1', 'TFEB', 'TGFA', 'ELOB', 'VEGFA']",0.9999956487937446,0,0,7
316,IL-2 signaling pathway WP49,0.5738387796074879,0.9900531511009871,0.5498822464221969,"['STAT5A', 'SOCS3', 'JUN', 'SYK', 'CISH', 'NMI', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,8
317,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5738387796074879,0.9900531511009871,0.5498822464221969,"['KISS1', 'PRKCH', 'STAR', 'CYP11A1', 'FSHR', 'HSD3B1', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,8
318,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.574036433092647,0.9806584937950037,0.544326669296608,"['YAP1', 'STAT5A', 'MMP2', 'TIE1', 'FOXO1', 'EGFR', 'NFKBIA', 'CASP7', 'RAD51', 'TNIP3', 'STMN1', 'HRAS', 'ANGPTL1', 'MAPK3']",0.9999956487937446,0,0,14
319,T-cell receptor (TCR) signaling pathway WP69,0.5825903309067657,0.9737255782618459,0.5260757221244017,"['VAV3', 'JUN', 'CD83', 'FYB1', 'NFATC2', 'NFATC1', 'VAV1', 'NFKBIA', 'ZAP70', 'MAP3K8', 'LCP2', 'CD247', 'VIM', 'HRAS', 'CARD11', 'MAPK3']",0.9999956487937446,0,0,16
320,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5966614732905061,1.0125882079251427,0.5229059910426348,"['CDH1', 'TULP3', 'PMAIP1']",0.9999956487937446,0,0,3
321,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5966614732905061,1.0125882079251427,0.5229059910426348,"['IFIH1', 'OAS1', 'CGAS']",0.9999956487937446,0,0,3
322,Phytochemical activity on NRF2 transcriptional activation WP3,0.5966614732905061,1.0125882079251427,0.5229059910426348,"['CEBPB', 'HMOX1', 'SLC7A11']",0.9999956487937446,0,0,3
323,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5968842834550612,0.990064467197573,0.5109049614290058,"['LDHA', 'PDHB', 'ACACB', 'VEGFA']",0.9999956487937446,0,0,4
324,PPAR-alpha pathway WP2878,0.5968842834550612,0.990064467197573,0.5109049614290058,"['CPT1A', 'CYP4A11', 'APOA1', 'PPARA']",0.9999956487937446,0,0,4
325,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5968842834550612,0.990064467197573,0.5109049614290058,"['HTR2B', 'ELK1', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,4
326,Physiological and pathological hypertrophy of the heart WP1528,0.5984486902847082,0.9770157969603953,0.50161406533788,"['JUN', 'LIFR', 'CALM1', 'CALM2', 'AGT']",0.9999956487937446,0,0,5
327,TLR4 Signaling and Tolerance WP3851,0.5984486902847082,0.9770157969603953,0.50161406533788,"['NFKBIA', 'INPP5D', 'IRF7', 'IRAK3', 'TLR4']",0.9999956487937446,0,0,5
328,Aspirin and miRNAs WP4707,0.5998013081921633,1.060830017055145,0.5422505104077585,"['PPARA', 'VEGFA']",0.9999956487937446,0,0,2
329,Estrogen metabolism WP697,0.5998013081921633,1.060830017055145,0.5422505104077585,"['CYP1B1', 'CYP3A4']",0.9999956487937446,0,0,2
330,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5998013081921633,1.060830017055145,0.5422505104077585,"['AHCY', 'MAT2B']",0.9999956487937446,0,0,2
331,Supression of HMGB1 mediated inflammation by THBD WP4479,0.5998013081921633,1.060830017055145,0.5422505104077585,"['NFKBIA', 'THBD']",0.9999956487937446,0,0,2
332,PDGFR-beta pathway WP3972,0.6006364564189236,0.9684986761030413,0.49370713950375217,"['PDGFRB', 'STAT5A', 'JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,6
333,Sphingolipid pathway WP1422,0.6006364564189236,0.9684986761030413,0.49370713950375217,"['UGT8', 'CERS4', 'ACER1', 'GAL3ST1', 'SPTLC3', 'SERINC1']",0.9999956487937446,0,0,6
334,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6031338232512359,0.9624990775005008,0.4866551046739607,"['JUN', 'HGF', 'GAB1', 'ELK1', 'HRAS', 'DOCK1', 'MAPK3']",0.9999956487937446,0,0,7
335,PDGF Pathway WP2526,0.6057854974508601,0.9580424718935998,0.48019897688659996,"['PDGFRB', 'NFKBIA', 'JUN', 'ARFIP2', 'ELK1', 'HRAS', 'VAV1', 'MAPK3']",0.9999956487937446,0,0,8
336,Notch Signaling WP268,0.6085080808952684,0.954599829108516,0.4741927747956961,"['NOTCH2', 'LFNG', 'NOTCH3', 'KAT2B', 'NOTCH1', 'DTX3L', 'MFNG', 'HES1', 'HES5']",0.9999956487937446,0,0,9
337,Ras signaling WP4223,0.6102512845231605,0.9621977788405335,0.47521453503274996,"['SHC4', 'CSF1R', 'SHC3', 'FLT1', 'PLA2G5', 'FOXO4', 'RASAL3', 'ELK1', 'ETS2', 'EGFR', 'GNG10', 'GNG3', 'HTR7', 'KDR', 'PLCG2', 'HRAS', 'MAPK3', 'PDGFRB', 'NTRK1', 'PDGFRA', 'NGFR', 'PLA2G12B', 'PLA2G4D', 'PLA2G4E', 'GAB1', 'GNG12', 'GNG11', 'ZAP70', 'CALM3', 'CALM1', 'FGFR4', 'CALM2', 'PLA1A', 'EPHA2', 'ARF6']",0.9999956487937446,0,0,35
338,GABA metabolism (aka GHB) WP4157,0.6148348458390271,1.237662214644312,0.602000869817394,['PON3'],0.9999956487937446,0,0,1
339,Sulindac Metabolic Pathway WP2542,0.6148348458390271,1.237662214644312,0.602000869817394,['CYP1B1'],0.9999956487937446,0,0,1
340,Retinoblastoma gene in cancer WP2446,0.6297737372110507,0.9417684628527361,0.4354687189057261,"['BARD1', 'CDT1', 'CDKN1B', 'RRM2', 'H2AFZ', 'SUV39H1', 'PRIM1', 'TTK', 'CCNA2', 'ANLN', 'CCND3', 'TFDP2', 'RPA3', 'STMN1', 'CDK2', 'MCM4', 'POLE']",0.9999956487937446,0,0,17
341,Base Excision Repair WP4752,0.6360756164391232,0.9280734206033011,0.4198955235119976,"['FEN1', 'NEIL2', 'POLD1', 'APEX1', 'POLE3', 'POLE']",0.9999956487937446,0,0,6
342,Type II interferon signaling (IFNG) WP619,0.6360756164391232,0.9280734206033011,0.4198955235119976,"['SOCS3', 'OAS1', 'CYBB', 'IRF8', 'GBP1', 'PSMB9']",0.9999956487937446,0,0,6
343,Copper homeostasis WP3286,0.6364583252346102,0.9280324601366743,0.41931878834716746,"['PRNP', 'JUN', 'STEAP4', 'SCO2', 'XAF1', 'STEAP2', 'SOD3', 'FOXO1']",0.9999956487937446,0,0,8
344,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6364583252346102,0.9280324601366743,0.41931878834716746,"['LYN', 'STAT5A', 'NFKBIA', 'HCK', 'CISH', 'BTK', 'RELB', 'MAPK3']",0.9999956487937446,0,0,8
345,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6372396683824311,0.9280938833570412,0.41820787309745117,"['JUP', 'WIF1', 'LEF1', 'LRP5', 'DKK1']",0.9999956487937446,0,0,5
346,Cytosolic DNA-sensing pathway WP4655,0.6400656909998921,0.9279709318894271,0.41404621443804446,"['NFKBIA', 'IL33', 'RNF125', 'CASP10', 'CCL4L2', 'CASP1', 'IRF7', 'POLR2E', 'CGAS', 'POLR3K', 'POLR2K']",0.9999956487937446,0,0,11
347,Triacylglyceride synthesis WP325,0.6401569381181255,0.9281143344709898,0.4139778968306248,"['GPD1', 'LPL', 'AGPAT1', 'PLPP3']",0.9999956487937446,0,0,4
348,Leptin Insulin Overlap WP3935,0.646373267557915,0.9281347739550754,0.40501771566576544,"['SOCS3', 'LEP', 'LEPR']",0.9999956487937446,0,0,3
349,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.646373267557915,0.9281347739550754,0.40501771566576544,"['PTTG1', 'BUB1B', 'MAD2L1']",0.9999956487937446,0,0,3
350,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.646373267557915,0.9281347739550754,0.40501771566576544,"['ACLY', 'SUCLG2', 'IDH3A']",0.9999956487937446,0,0,3
351,Tryptophan catabolism leading to NAD+ production WP4210,0.646373267557915,0.9281347739550754,0.40501771566576544,"['HAAO', 'KYNU', 'KMO']",0.9999956487937446,0,0,3
352,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.659944750915494,0.9281552018192155,0.38574052055474317,"['IL10RA', 'HMOX1']",0.9999956487937446,0,0,2
353,3q29 copy number variation syndrome WP4906,0.6656816330327812,0.9089428245642612,0.3698886026664054,"['STAT5A', 'CASP7', 'TM4SF19', 'JUN', 'TF', 'NCBP2', 'HFE', 'DYNLT3', 'MAD2L1BP', 'SLC51A', 'DYNLL2', 'HAMP']",0.9999956487937446,0,0,12
354,Fluoropyrimidine Activity WP1601,0.6695779140747941,0.8908821855435402,0.357339743711259,"['ABCC3', 'CDA', 'CYP2A6', 'RRM2', 'UPB1', 'ABCG2']",0.9999956487937446,0,0,6
355,Prion disease pathway WP3995,0.6695779140747941,0.8908821855435402,0.357339743711259,"['PRNP', 'HSPA5', 'EBF1', 'ELK1', 'MAPK3', 'BATF']",0.9999956487937446,0,0,6
356,Regulation of Actin Cytoskeleton WP51,0.6708054287860752,0.9276202749140894,0.3703766576541109,"['CHRM1', 'BRK1', 'FGF2', 'ACTB', 'EGFR', 'ACTG1', 'PIK3R5', 'FGF8', 'TMSB4X', 'PIP4K2A', 'PIP4K2C', 'CD14', 'WASF2', 'MAPK3', 'PDGFRB', 'PDGFRA', 'GSN', 'MSN', 'GNG12', 'VAV1', 'FGF17', 'VIL1', 'DIAPH3', 'MYL3', 'EZR', 'FGFR4', 'DOCK1', 'FGF10']",0.9999956487937446,0,0,28
357,Integrin-mediated Cell Adhesion WP185,0.6732860355813023,0.9156864272545506,0.3622318372181066,"['VAV3', 'SHC3', 'ITGAM', 'CAV3', 'ITGB5', 'ITGB4', 'ITGA2', 'ITGB2', 'CAPNS1', 'ITGA10', 'SELENOP', 'ITGAX', 'ITGA8', 'RHO', 'ITGB8', 'ITGA6', 'HRAS', 'DOCK1', 'TNS1']",0.9999956487937446,0,0,19
358,Gastric Cancer Network 2 WP2363,0.6736197273065513,0.8838311996206734,0.34919245334708676,"['PLAC8', 'S100A6', 'COL9A1', 'CACYBP', 'EGFR']",0.9999956487937446,0,0,5
359,Urea cycle and metabolism of amino groups WP497,0.6802628681079615,0.8734524526534163,0.33652025384075357,"['OAT', 'CKM', 'ODC1', 'PYCR3']",0.9999956487937446,0,0,4
360,MECP2 and Associated Rett Syndrome WP3584,0.6886523927177431,0.8934247906303795,0.33326410491757635,"['MPP1', 'ARHGEF26', 'CEBPD', 'DLX5', 'DLX6', 'GAD1', 'FGF2', 'MYT1', 'GABRR2', 'BCL6', 'SST', 'SGK1', 'FKBP5']",0.9999956487937446,0,0,13
361,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6887866192082921,0.8906955530216648,0.332072458228954,"['JUN', 'PRKCH', 'OAS2', 'VDR', 'PLCG2', 'NOD2', 'HRAS', 'TLR4', 'IFI44L', 'TLR2', 'RELB', 'MAPK3']",0.9999956487937446,0,0,12
362,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6895687939203688,0.8996125639961257,0.3343759261545832,"['PDGFRB', 'SHC4', 'PDGFRA', 'SHC3', 'HGF', 'GAB1', 'TGFA', 'FGF2', 'EGFR', 'VEGFA', 'ERBB3', 'AXL', 'KDR', 'PLCG2', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,16
363,Phosphodiesterases in neuronal function WP4222,0.690094613010821,0.8836657169990503,0.3277750938620011,"['ADCY10', 'PDE10A', 'ADORA2A', 'PDE6H', 'ADCY4', 'PDE6C', 'PDE5A', 'CHRFAM7A', 'PDE6A', 'PDE9A']",0.9999956487937446,0,0,10
364,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.6915612906884341,0.8566741759804029,0.315944432237189,"['RAB27A', 'SYTL4', 'SYTL3']",0.9999956487937446,0,0,3
365,Glutathione metabolism WP100,0.6915612906884341,0.8566741759804029,0.315944432237189,"['GGT5', 'GPX4', 'GPX3']",0.9999956487937446,0,0,3
366,Mammalian disorder of sexual development WP4842,0.6915612906884341,0.8566741759804029,0.315944432237189,"['EMX2', 'FST', 'SOX9']",0.9999956487937446,0,0,3
367,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6935707583208635,0.8733083210505159,0.31954527324302573,"['CASP7', 'JUN', 'RRM2', 'MYOF', 'LEF1', 'CD44', 'MAPK3', 'VEGFA']",0.9999956487937446,0,0,8
368,Benzene metabolism WP3891,0.6965820550317576,0.9281756180733163,0.33560016322918557,['EPHX1'],0.9999956487937446,0,0,1
369,miR-517 relationship with ARCN1 and USP1 WP3596,0.6965820550317576,0.9281756180733163,0.33560016322918557,['ARCN1'],0.9999956487937446,0,0,1
370,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.6965820550317576,0.9281756180733163,0.33560016322918557,['FOXO1'],0.9999956487937446,0,0,1
371,Steroid Biosynthesis WP496,0.6965820550317576,0.9281756180733163,0.33560016322918557,['HSD3B1'],0.9999956487937446,0,0,1
372,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.7125905570160312,0.824963678857937,0.2795375214566567,"['HMGCS1', 'HMGCR']",0.9999956487937446,0,0,2
373,"NAD metabolism, sirtuins and aging WP3630",0.7125905570160312,0.824963678857937,0.2795375214566567,"['ROS1', 'FOXO1']",0.9999956487937446,0,0,2
374,Serotonin Transporter Activity WP1455,0.7125905570160312,0.824963678857937,0.2795375214566567,"['IL1R1', 'TGFB1I1']",0.9999956487937446,0,0,2
375,Prolactin Signaling Pathway WP2037,0.729164244995751,0.8657824681498384,0.27346282151701506,"['STAT5A', 'JUN', 'CISH', 'ELK1', 'PRLR', 'VAV1', 'NFKBIA', 'ZAP70', 'SOCS3', 'PTPN6', 'NEK3', 'HRAS', 'YWHAG', 'MAPK3']",0.9999956487937446,0,0,14
376,CAMKK2  Pathway WP4874,0.7304254003650522,0.8247644343261873,0.2590817460160684,"['MAP1LC3A', 'HMOX1', 'NFATC2', 'CALM1', 'CALM2', 'MAPK3']",0.9999956487937446,0,0,6
377,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.7322453436984737,0.795422234859255,0.24788510861606228,"['SPP1', 'ALPL', 'ROS1']",0.9999956487937446,0,0,3
378,Signal transduction through IL1R WP4496,0.7388122503512102,0.8068526192095986,0.24424352579462666,"['NFKBIA', 'JUN', 'IL1R1', 'TOLLIP', 'IRAK3']",0.9999956487937446,0,0,5
379,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.7402305626979451,0.8349544289376246,0.25114892354988033,"['NFKBIA', 'RPS6KA5', 'IL1R1', 'TOLLIP', 'MKNK2', 'IRF7', 'MAP3K8', 'ELK1', 'MAPK3']",0.9999956487937446,0,0,9
380,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.745434736237283,0.8603004433856132,0.25274568187936736,"['KLB', 'NOTCH1', 'UCP1', 'DIO3', 'ITPR2', 'TRH', 'FOXO1', 'TSHR', 'MC4R', 'SLCO1C1', 'CREB3', 'TPO', 'NHSL1', 'TG', 'PRDM16', 'HRAS']",0.9999956487937446,0,0,16
381,DNA Mismatch Repair WP531,0.7507460508163429,0.7813903359080294,0.224015101699182,"['POLD1', 'RPA3', 'POLE3', 'POLE']",0.9999956487937446,0,0,4
382,IL-7 signaling pathway WP205,0.7507460508163429,0.7813903359080294,0.224015101699182,"['STAT5A', 'CDKN1B', 'IL7', 'MAPK3']",0.9999956487937446,0,0,4
383,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7507460508163429,0.7813903359080294,0.224015101699182,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.9999956487937446,0,0,4
384,p38 MAPK Signaling Pathway WP400,0.7577021359267867,0.7952475811041548,0.22065331528875132,"['RPS6KA5', 'DDIT3', 'HSPB1', 'ELK1', 'HRAS', 'MEF2D']",0.9999956487937446,0,0,6
385,Wnt signaling in kidney disease WP4150,0.7577021359267867,0.7952475811041548,0.22065331528875132,"['WNT10A', 'FZD2', 'LRP5', 'FZD9', 'WNT16', 'WNT2']",0.9999956487937446,0,0,6
386,Biomarkers for urea cycle disorders WP4583,0.7582118291108845,0.7424104604889141,0.20549362841698285,"['F7', 'GOT1']",0.9999956487937446,0,0,2
387,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.7582118291108845,0.7424104604889141,0.20549362841698285,"['BMPR1B', 'SMAD6']",0.9999956487937446,0,0,2
388,Purine metabolism WP4792,0.7582118291108845,0.7424104604889141,0.20549362841698285,"['PRPS1', 'XDH']",0.9999956487937446,0,0,2
389,RalA downstream regulated genes WP2290,0.7582118291108845,0.7424104604889141,0.20549362841698285,"['YBX3', 'HRAS']",0.9999956487937446,0,0,2
390,Genotoxicity pathway WP4286,0.7583024799410497,0.8245647356758468,0.22813473552725774,"['IKBIP', 'ACTA2', 'CEBPD', 'BLOC1S2', 'PCDH8', 'HIST1H1E', 'TRIAP1', 'TRIM22', 'DDB2', 'HIST1H2BC']",0.9999956487937446,0,0,10
391,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.7609831006241838,0.742483660130719,0.20280505202565904,['CYP2J2'],0.9999956487937446,0,0,1
392,Effects of nitric oxide WP1995,0.7609831006241838,0.742483660130719,0.20280505202565904,['XDH'],0.9999956487937446,0,0,1
393,miRNA Biogenesis WP2338,0.7609831006241838,0.742483660130719,0.20280505202565904,['RAN'],0.9999956487937446,0,0,1
394,Somatic sex determination WP4814,0.7609831006241838,0.742483660130719,0.20280505202565904,['SOX9'],0.9999956487937446,0,0,1
395,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.7675988389738673,0.7731744902797535,0.20449539576258854,"['CDKN1B', 'TFEB', 'FOXO4', 'HRAS', 'FOXO1']",0.9999956487937446,0,0,5
396,SARS-CoV-2 mitochondrial interactions WP5038,0.7675988389738673,0.7731744902797535,0.20449539576258854,"['IFIH1', 'IRF7', 'CGAS', 'TLR7', 'TLR3']",0.9999956487937446,0,0,5
397,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7685685117648542,0.7423372192209269,0.19540213765445202,"['RAB27A', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,3
398,Methionine De Novo and Salvage Pathway WP3580,0.7685685117648542,0.7423372192209269,0.19540213765445202,"['AHCY', 'ODC1', 'MAT2B']",0.9999956487937446,0,0,3
399,TP53 network WP1742,0.7685685117648542,0.7423372192209269,0.19540213765445202,"['CDKN2A', 'TNFSF10', 'PMAIP1']",0.9999956487937446,0,0,3
400,ATM Signaling Pathway WP2516,0.7744330513185296,0.7871369545152637,0.20121114725777212,"['NFKBIA', 'JUN', 'RAD51', 'CRADD', 'CHEK2', 'CDK2', 'RAD9A']",0.9999956487937446,0,0,7
401,Gastric Cancer Network 1 WP2361,0.7812054820790991,0.7422639362912401,0.18327763074416878,"['NOTCH1', 'MCM4', 'GATD3B', 'GATD3A']",0.9999956487937446,0,0,4
402,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7812054820790991,0.7422639362912401,0.18327763074416878,"['CHEK2', 'TNFRSF10B', 'PMAIP1', 'DDB2']",0.9999956487937446,0,0,4
403,Urea cycle and associated pathways WP4595,0.7812054820790991,0.7422639362912401,0.18327763074416878,"['SLC25A15', 'OAT', 'GOT1', 'MDH2']",0.9999956487937446,0,0,4
404,Oxidative phosphorylation WP623,0.7834463532583302,0.7950726288806608,0.19403961395424313,"['ATP5F1B', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC3', 'ATP5MF', 'ATP5MC1']",0.9999956487937446,0,0,9
405,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7894277731330629,0.7811413499580386,0.18469847705157816,"['PPP1R15A', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'PPP1R1A', 'PPP1R1C', 'DDIT3']",0.9999956487937446,0,0,8
406,TNF-alpha signaling pathway WP231,0.7943367750066255,0.8242643328259767,0.18978501445016663,"['HSP90AA1', 'JUN', 'TNFAIP3', 'OTUD7B', 'CYBA', 'CFLAR', 'TNFRSF1B', 'SELE', 'NFKBIA', 'CASP7', 'RFK', 'MAP3K8', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.9999956487937446,0,0,16
407,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.7974184846231964,0.6748669181869864,0.15277344616682553,"['GPRC5B', 'GPRC5C']",0.9999956487937446,0,0,2
408,Homologous recombination WP186,0.7974184846231964,0.6748669181869864,0.15277344616682553,"['RAD51', 'POLD1']",0.9999956487937446,0,0,2
409,Osteopontin Signaling WP1434,0.7974184846231964,0.6748669181869864,0.15277344616682553,"['SPP1', 'MAPK3']",0.9999956487937446,0,0,2
410,Alzheimer's disease WP2059,0.7993666108559437,0.8114214917284654,0.18170615968481343,"['ATP5MD', 'ATP2A2', 'ITPR2', 'LPL', 'RYR3', 'CASP7', 'CYCS', 'CALM3', 'APOE', 'CALM1', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.9999956487937446,0,0,14
411,Hepatitis B infection WP4666,0.8083084322899143,0.8426973598647418,0.1793357483289899,"['YWHAB', 'ELK1', 'IFIH1', 'CASP10', 'CREB3L1', 'CREB3L2', 'HRAS', 'MAPK3', 'STAT5A', 'JUN', 'EGR2', 'TICAM2', 'EGR3', 'ATP6AP1', 'SLC10A1', 'NFATC2', 'NFATC1', 'TGFBR2', 'DDB2', 'CREB3', 'IRF7', 'CYCS', 'TLR4', 'TLR3', 'TLR2']",0.9999956487937446,0,0,25
412,EPO Receptor Signaling WP581,0.8086275000990878,0.7068638604474782,0.15014983902895643,"['STAT5A', 'PTPRC', 'CISH', 'MAPK3']",0.9999956487937446,0,0,4
413,Pathways affected in adenoid cystic carcinoma WP3651,0.8103639918727409,0.7847238967928624,0.16500527455598604,"['MORF4L1', 'CEBPA', 'NOTCH1', 'UHRF1', 'CHEK2', 'INSRR', 'ERBIN', 'HIST1H1E', 'IL17RD', 'FGFR4', 'HRAS']",0.9999956487937446,0,0,11
414,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.8117178830370373,0.6186890215023207,0.1290600356960892,['CASP1'],0.9999956487937446,0,0,1
415,"Cerebral organic acidurias, including diseases WP4519",0.8117178830370373,0.6186890215023207,0.1290600356960892,['MDH2'],0.9999956487937446,0,0,1
416,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.8117178830370373,0.6186890215023207,0.1290600356960892,['DHCR24'],0.9999956487937446,0,0,1
417,Disorders of the Krebs cycle WP4236,0.8117178830370373,0.6186890215023207,0.1290600356960892,['SUCLG2'],0.9999956487937446,0,0,1
418,Glial Cell Differentiation WP2276,0.8117178830370373,0.6186890215023207,0.1290600356960892,['MSN'],0.9999956487937446,0,0,1
419,Glucuronidation WP698,0.8117178830370373,0.6186890215023207,0.1290600356960892,['PGM5'],0.9999956487937446,0,0,1
420,Molybdenum cofactor (Moco) biosynthesis WP4507,0.8117178830370373,0.6186890215023207,0.1290600356960892,['XDH'],0.9999956487937446,0,0,1
421,miRNA regulation of prostate cancer signaling pathways WP3981,0.8178121670953981,0.7135901083269505,0.14351909315771463,"['PDGFRB', 'NFKBIA', 'CDKN1B', 'CREB3L1', 'FOXO1']",0.9999956487937446,0,0,5
422,16p11.2 proximal deletion syndrome WP4949,0.822068898278118,0.7808917961951629,0.1530009648562385,"['SPN', 'PARP4', 'MVP', 'MSN', 'GDPD3', 'TBX6', 'EZR', 'ALDOA', 'SEZ6L2', 'CDIPT', 'YPEL3', 'MAPK3']",0.9999956487937446,0,0,12
423,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8266220421396753,0.7698586384337848,0.1465870213155229,"['EGR1', 'CCND3', 'JUN', 'CDKN1B', 'KCNIP3', 'APEX1', 'CDK2', 'CGA', 'HRAS', 'TSHR', 'MAPK3']",0.9999956487937446,0,0,11
424,G13 Signaling Pathway WP524,0.8272230155364767,0.7181229001046505,0.1362142354819139,"['RTKN', 'ARHGDIB', 'ARHGDIG', 'PIP4K2A', 'CALM1', 'CALM2']",0.9999956487937446,0,0,6
425,Vitamin D in inflammatory diseases WP4482,0.8291007908996725,0.6549030758166218,0.12273771030205856,"['NFKBIA', 'VDR', 'NFATC1']",0.9999956487937446,0,0,3
426,Amino Acid metabolism WP3925,0.8291304150214346,0.7867119569914778,0.1474123715873463,"['AOC3', 'TPH1', 'OAT', 'GOT1', 'MDH2', 'ODC1', 'DBH', 'ACLY', 'TPO', 'LDHA', 'PKM', 'ALDH1A1', 'PDK4', 'ACSS1']",0.9999956487937446,0,0,14
427,IL-9 signaling pathway WP22,0.8308779241423631,0.6185806329353799,0.11460591677099405,"['STAT5A', 'MAPK3']",0.9999956487937446,0,0,2
428,Kit receptor signaling pathway WP304,0.8318983450788715,0.757020757020757,0.13932590568154776,"['LYN', 'STAT5A', 'INPP5D', 'BTK', 'PTPN6', 'JUNB', 'HRAS', 'VAV1', 'MAPK3', 'TBX2']",0.9999956487937446,0,0,10
429,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8394355550638606,0.6871081607923714,0.12026149836505594,"['HEXIM1', 'NFKBIA', 'SUPT4H1', 'NFATC2', 'NFATC1']",0.9999956487937446,0,0,5
430,Gastrin signaling pathway WP4659,0.8408227364236268,0.8005472462413337,0.13879441319299887,"['CHGA', 'EGR1', 'JUN', 'PRKCH', 'CDKN1B', 'SERPINB2', 'CDKN2A', 'KLF4', 'ELK1', 'FOXO1', 'EGFR', 'VEGFA', 'NFKBIA', 'CCKBR', 'CDH1', 'HRAS', 'MEF2D', 'CD44', 'MAPK3']",0.9999956487937446,0,0,19
431,Melanoma WP4685,0.841799207069105,0.7555439451991176,0.13011506711819032,"['PREX2', 'CDH1', 'CDKN2A', 'KDR', 'CALM3', 'CALM1', 'ELK1', 'HRAS', 'CALM2', 'DDB2', 'MAPK3']",0.9999956487937446,0,0,11
432,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8452633632479932,0.7238179898883271,0.1216788908772976,"['CD160', 'CXCL17', 'IRF7', 'CCL3', 'CXCL1', 'TLR7', 'CXCL13', 'CXCL5']",0.9999956487937446,0,0,8
433,Disorders of Folate Metabolism and Transport WP4259,0.8516858063176973,0.5302642796248934,0.08512735062417229,['ALDH1L1'],0.9999956487937446,0,0,1
434,Ketogenesis and Ketolysis WP4742,0.8516858063176973,0.5302642796248934,0.08512735062417229,['UCP2'],0.9999956487937446,0,0,1
435,Liver X receptor pathway WP2874,0.8516858063176973,0.5302642796248934,0.08512735062417229,['CYP3A4'],0.9999956487937446,0,0,1
436,Methylation Pathways WP704,0.8516858063176973,0.5302642796248934,0.08512735062417229,['MAT2B'],0.9999956487937446,0,0,1
437,Mitochondrial CII Assembly WP4920,0.8516858063176973,0.5302642796248934,0.08512735062417229,['SDHAF1'],0.9999956487937446,0,0,1
438,Serine Metabolism WP4688,0.8516858063176973,0.5302642796248934,0.08512735062417229,['PHGDH'],0.9999956487937446,0,0,1
439,Ectoderm Differentiation WP2858,0.8546068761317289,0.8043255404902315,0.12637056953805068,"['TFAP2C', 'TCF7L1', 'EDA', 'JUP', 'ARHGDIG', 'STC1', 'TNFRSF11B', 'NFATC1', 'PAX6', 'RRBP1', 'NR2F2', 'ARHGAP15', 'JAKMIP1', 'ZFHX4', 'EDA2R', 'GLI3', 'SOX2', 'PPFIBP2', 'MAFB', 'BOC', 'PIM1', 'TBL1X', 'LY6E']",0.9999956487937446,0,0,23
440,Glioblastoma signaling pathways WP2261,0.8554580105335554,0.7634559242978424,0.11918941708334592,"['PDGFRB', 'PDGFRA', 'CDKN1B', 'PRKCH', 'CDKN2A', 'GAB1', 'FOXO4', 'FOXO1', 'EGFR', 'ERBB3', 'CDK2', 'PLCG2', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,14
441,MAPK Cascade WP422,0.8589016165841274,0.6625177809388336,0.10076954813338841,"['JUN', 'ELK1', 'HRAS', 'SIPA1', 'MAPK3']",0.9999956487937446,0,0,5
442,Biomarkers for pyrimidine metabolism disorders WP4584,0.8592631931597872,0.5709537761840207,0.08660227396512535,"['RRM2', 'UPB1']",0.9999956487937446,0,0,2
443,Cholesterol Biosynthesis Pathway WP197,0.8592631931597872,0.5709537761840207,0.08660227396512535,"['HMGCS1', 'HMGCR']",0.9999956487937446,0,0,2
444,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.8592631931597872,0.5709537761840207,0.08660227396512535,"['FRAT1', 'SOX9']",0.9999956487937446,0,0,2
445,miRNAs involved in DNA damage response WP1545,0.8592631931597872,0.5709537761840207,0.08660227396512535,"['CCND3', 'CDKN1B']",0.9999956487937446,0,0,2
446,Overview of nanoparticle effects WP3287,0.8592631931597872,0.5709537761840207,0.08660227396512535,"['CCND3', 'HMOX1']",0.9999956487937446,0,0,2
447,Small cell lung cancer WP4658,0.8603556766622354,0.7704441677044417,0.11588204324128364,"['CDKN1B', 'LAMB3', 'LAMB2', 'ITGA2', 'LAMA4', 'LAMC2', 'FHIT', 'DDB2', 'NFKBIA', 'CDK2', 'CKS2', 'COL4A6', 'COL4A5', 'CYCS', 'ITGA6', 'SKP1']",0.9999956487937446,0,0,16
448,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8640066632871867,0.6744968179231128,0.09859443615868241,"['NFKBIA', 'CASP7', 'JUN', 'TNFRSF12A', 'RELB', 'MAPK3']",0.9999956487937446,0,0,6
449,16p11.2 distal deletion syndrome WP4950,0.8744024085253953,0.6183636708380735,0.08299342508959959,"['C3', 'PLN', 'KDR', 'NFATC2']",0.9999956487937446,0,0,4
450,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8755044213237295,0.5858761204974335,0.07789520483817836,"['SUV39H1', 'LEF1', 'HIST1H3E']",0.9999956487937446,0,0,3
451,Fatty Acid Biosynthesis WP357,0.8755044213237295,0.5858761204974335,0.07789520483817836,"['ACLY', 'ECHDC3', 'ACACB']",0.9999956487937446,0,0,3
452,Hippo-Yap signaling pathway WP4537,0.8755044213237295,0.5858761204974335,0.07789520483817836,"['LATS2', 'TEAD2', 'TEAD3']",0.9999956487937446,0,0,3
453,NAD+ biosynthetic pathways WP3645,0.8755044213237295,0.5858761204974335,0.07789520483817836,"['PARP4', 'CD38', 'ACMSD']",0.9999956487937446,0,0,3
454,NRF2-ARE regulation WP4357,0.8755044213237295,0.5858761204974335,0.07789520483817836,"['CEBPB', 'HMOX1', 'SLC7A11']",0.9999956487937446,0,0,3
455,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8755044213237295,0.5858761204974335,0.07789520483817836,"['GNA14', 'CA8', 'RYR3']",0.9999956487937446,0,0,3
456,Amyotrophic lateral sclerosis (ALS) WP2447,0.8763497652444858,0.6396232893510571,0.08442387306302251,"['SLC1A2', 'CASP1', 'NEFL', 'NEFM', 'NEFH']",0.9999956487937446,0,0,5
457,Parkinson's disease pathway WP2371,0.8763497652444858,0.6396232893510571,0.08442387306302251,"['CASP7', 'PINK1', 'UBA7', 'CASP6', 'CYCS']",0.9999956487937446,0,0,5
458,Target Of Rapamycin (TOR) Signaling WP1471,0.8763497652444858,0.6396232893510571,0.08442387306302251,"['FKBP1A', 'RRAGA', 'DDIT4L', 'PRR5L', 'HMGCR']",0.9999956487937446,0,0,5
459,Common Pathways Underlying Drug Addiction WP2636,0.8798137374805165,0.6546084569285882,0.08381937643869107,"['PPP1R1A', 'CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.9999956487937446,0,0,6
460,Notch Signaling Pathway Netpath WP61,0.8812453140978334,0.6953681287382512,0.08790791188900725,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'MAML2', 'HEY1', 'HEY2', 'HES1', 'HES5', 'SKP1']",0.9999956487937446,0,0,9
461,ATR Signaling WP3875,0.8831712813386691,0.463945723216823,0.057638816815954674,['RAD9A'],0.9999956487937446,0,0,1
462,Biotin Metabolism (including IEMs) WP5031,0.8831712813386691,0.463945723216823,0.057638816815954674,['ACACB'],0.9999956487937446,0,0,1
463,Cell Differentiation - Index WP2029,0.8831712813386691,0.463945723216823,0.057638816815954674,['MEF2D'],0.9999956487937446,0,0,1
464,"Degradation pathway of sphingolipids, including diseases WP4153",0.8831712813386691,0.463945723216823,0.057638816815954674,['NEU1'],0.9999956487937446,0,0,1
465,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.8831712813386691,0.463945723216823,0.057638816815954674,['TIFA'],0.9999956487937446,0,0,1
466,NLR Proteins WP288,0.8831712813386691,0.463945723216823,0.057638816815954674,['ERBIN'],0.9999956487937446,0,0,1
467,Thiamine metabolic pathways WP4297,0.8831712813386691,0.463945723216823,0.057638816815954674,['BCKDK'],0.9999956487937446,0,0,1
468,Urea cycle and related diseases WP4571,0.8831712813386691,0.463945723216823,0.057638816815954674,['SLC25A15'],0.9999956487937446,0,0,1
469,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8832205451651585,0.5301307561114269,0.06583181835533473,"['MKNK2', 'MAPK3']",0.9999956487937446,0,0,2
470,Glycosaminoglycan degradation WP4815,0.8832205451651585,0.5301307561114269,0.06583181835533473,"['HPSE2', 'IDS']",0.9999956487937446,0,0,2
471,NAD+ metabolism WP3644,0.8832205451651585,0.5301307561114269,0.06583181835533473,"['NRK', 'CD38']",0.9999956487937446,0,0,2
472,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8832205451651585,0.5301307561114269,0.06583181835533473,"['SFRP4', 'LEF1']",0.9999956487937446,0,0,2
473,Type II diabetes mellitus WP1584,0.8832205451651585,0.5301307561114269,0.06583181835533473,"['KCNJ11', 'PIK3R5']",0.9999956487937446,0,0,2
474,RANKL/RANK signaling pathway WP2018,0.8886303272047409,0.6743114516463036,0.0796186232784613,"['LYN', 'NFKBIA', 'JUN', 'SYK', 'TNFRSF11B', 'NFATC1', 'RELB', 'MAPK3']",0.9999956487937446,0,0,8
475,Wnt signaling pathway and pluripotency WP399,0.8912801476565949,0.7413812785388127,0.0853303766565458,"['WNT10A', 'JUN', 'TCF7L1', 'PRKCH', 'FZD2', 'LEF1', 'FZD9', 'LRP5', 'PPM1J', 'WNT16', 'NKD1', 'SOX2', 'FRAT1', 'CCND3', 'WNT2', 'CD44']",0.9999956487937446,0,0,16
476,Sphingolipid Metabolism (general overview) WP4725,0.8942181264769683,0.5565396644867785,0.062224220068708376,"['CERS4', 'UGT8', 'PLPP3']",0.9999956487937446,0,0,3
477,Trans-sulfuration and one-carbon metabolism WP2525,0.8942181264769683,0.5565396644867785,0.062224220068708376,"['AHCY', 'PHGDH', 'MAT2B']",0.9999956487937446,0,0,3
478,Nonalcoholic fatty liver disease WP4396,0.8964720618699478,0.7732961894338872,0.08451210993049654,"['CEBPA', 'XBP1', 'JUN', 'COX7B', 'GSK3A', 'NDUFB10', 'PKLR', 'NDUFB11', 'NDUFB5', 'NDUFA4', 'COX4I1', 'UQCR11', 'UQCR10', 'COX7A1', 'COX7C', 'UQCRH', 'SOCS3', 'CASP7', 'DDIT3', 'LEP', 'LEPR', 'CYCS', 'UQCRFS1', 'PPARA']",0.9999956487937446,0,0,24
479,Head and Neck Squamous Cell Carcinoma WP4674,0.9027200411098738,0.691249136602731,0.0707443760282025,"['NOTCH2', 'FKBP1A', 'NOTCH1', 'TERT', 'CDKN2A', 'GAB1', 'HRAS', 'EGFR', 'TGFBR2', 'PIK3R5', 'VEGFA']",0.9999956487937446,0,0,11
480,Canonical and non-canonical TGF-B signaling WP3874,0.903350509855269,0.49475080538184574,0.05028876718479449,"['LOXL1', 'TGFBR2']",0.9999956487937446,0,0,2
481,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.903350509855269,0.49475080538184574,0.05028876718479449,"['JUN', 'MAPK3']",0.9999956487937446,0,0,2
482,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.903350509855269,0.49475080538184574,0.05028876718479449,"['CPT1A', 'ACSF2']",0.9999956487937446,0,0,2
483,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.903350509855269,0.49475080538184574,0.05028876718479449,"['EIF1AX', 'EIF3CL']",0.9999956487937446,0,0,2
484,Pyrimidine metabolism and related diseases WP4225,0.903350509855269,0.49475080538184574,0.05028876718479449,"['RRM2', 'UPB1']",0.9999956487937446,0,0,2
485,Autosomal recessive Osteopetrosis pathways WP4788,0.9079741434529645,0.4123646237883237,0.03980942394321488,['TCIRG1'],0.9999956487937446,0,0,1
486,Dopamine metabolism WP2436,0.9079741434529645,0.4123646237883237,0.03980942394321488,['TYR'],0.9999956487937446,0,0,1
487,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.9079741434529645,0.4123646237883237,0.03980942394321488,['MAFK'],0.9999956487937446,0,0,1
488,TCA cycle in senescence WP5050,0.9079741434529645,0.4123646237883237,0.03980942394321488,['GOT1'],0.9999956487937446,0,0,1
489,Valproic acid pathway WP3871,0.9079741434529645,0.4123646237883237,0.03980942394321488,['CYP2A6'],0.9999956487937446,0,0,1
490,Sphingolipid Metabolism (integrated pathway) WP4726,0.9103627398657143,0.5299971566676145,0.04977316911643478,"['UGT8', 'CERS4', 'PLPP3']",0.9999956487937446,0,0,3
491,ErbB signaling pathway WP673,0.9157996732639561,0.7012303233067637,0.06167856120409724,"['SHC4', 'STAT5A', 'JUN', 'CDKN1B', 'SHC3', 'GAB1', 'TGFA', 'ELK1', 'FOXO1', 'EGFR', 'ERBB3', 'PLCG2', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,14
492,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9180515191119611,0.5795252489331437,0.04955043390563637,"['NGFR', 'GABRA1', 'SLC12A5', 'GABRE', 'GABRD']",0.9999956487937446,0,0,5
493,Phosphoinositides metabolism WP4971,0.9180515191119611,0.5795252489331437,0.04955043390563637,"['PIP4P1', 'INPP5D', 'PLCG2', 'PIP4K2A', 'PIP4K2C']",0.9999956487937446,0,0,5
494,Pyrimidine metabolism WP4022,0.9198148131356865,0.688366124893071,0.05753565024549976,"['CDA', 'RRM2', 'PRIM1', 'NME2', 'UPB1', 'POLD1', 'POLE3', 'POLR2E', 'CMPK2', 'POLR2I', 'POLE', 'POLR3K', 'POLR2K']",0.9999956487937446,0,0,13
495,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.9201981982944436,0.4637933484934622,0.03857193001430887,"['SUV39H1', 'IGFBP7']",0.9999956487937446,0,0,2
496,PPAR signaling pathway WP3942,0.921352892281812,0.6311248970096447,0.05169679977477151,"['CYP27A1', 'CPT1A', 'CYP4A11', 'UCP1', 'APOA1', 'LPL', 'ACSBG1', 'PPARA']",0.9999956487937446,0,0,8
497,DNA damage response WP707,0.926191537359531,0.6503723696706153,0.04986679540562125,"['CCND3', 'CDKN1B', 'RAD51', 'CHEK2', 'CDK2', 'PMAIP1', 'TNFRSF10B', 'CYCS', 'DDB2', 'RAD9A']",0.9999956487937446,0,0,10
498,Nucleotide Excision Repair WP4753,0.9283906228632552,0.5855225713686607,0.04350591086343117,"['CETN2', 'POLD1', 'RPA3', 'POLE3', 'POLE', 'DDB2']",0.9999956487937446,0,0,6
499,One-carbon metabolism and related pathways WP3940,0.9283906228632552,0.5855225713686607,0.04350591086343117,"['DMGDH', 'GPX4', 'GPX3', 'GAD1', 'GAD2', 'SOD3']",0.9999956487937446,0,0,6
500,Regulation of Microtubule Cytoskeleton WP2038,0.9283906228632552,0.5855225713686607,0.04350591086343117,"['SPRED1', 'PARD6A', 'STMN1', 'RHO', 'PHLDB2', 'F2RL2']",0.9999956487937446,0,0,6
501,BDNF-TrkB Signaling WP3676,0.9311021868858566,0.5298634812286689,0.03782496554771137,"['ARC', 'HOMER1', 'GAB1', 'HRAS']",0.9999956487937446,0,0,4
502,p53 transcriptional gene network WP4963,0.9319550326724386,0.6295255343045845,0.044363113673455544,"['NOTCH1', 'ADORA2B', 'PMAIP1', 'SLC7A11', 'THBS1', 'CX3CL1', 'DDB2', 'RPRM', 'TNFRSF10D']",0.9999956487937446,0,0,9
503,Ebstein-Barr virus LMP1 signaling WP262,0.9342497783597259,0.4364779453566532,0.02968549702060895,"['NFKBIA', 'HSP90AA1']",0.9999956487937446,0,0,2
504,SARS coronavirus and innate immunity WP4912,0.9342497783597259,0.4364779453566532,0.02968549702060895,"['IFIH1', 'TLR3']",0.9999956487937446,0,0,2
505,TGF-beta Signaling Pathway WP366,0.9350942006314502,0.7202613445111302,0.04833530221838154,"['KLF10', 'YAP1', 'JUN', 'CITED1', 'ITGB4', 'TGFB1I1', 'ITGA2', 'LIMK2', 'TNC', 'NEDD9', 'THBS1', 'TGFBR2', 'TGFBR3', 'DAB2', 'COL1A2', 'PARD6A', 'TERT', 'STRAP', 'FOSB', 'JUNB', 'SKP1']",0.9999956487937446,0,0,21
506,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.936113196442245,0.48383627350385083,0.03194232570944061,"['PTH1R', 'SOX9', 'MAPK3']",0.9999956487937446,0,0,3
507,Leptin signaling pathway WP2034,0.9361197488659073,0.647161267850923,0.04272032798382567,"['SOCS3', 'GSK3A', 'CISH', 'LEP', 'LEPR', 'PLCG2', 'ELK1', 'HRAS', 'ACACB', 'FOXO1', 'MAPK3']",0.9999956487937446,0,0,11
508,Translation Factors WP107,0.9374831134916962,0.5898545661568719,0.03807896610466085,"['EIF4A2', 'EEF1G', 'EIF1AX', 'EEF1A2', 'EIF4H', 'EIF3CL', 'GSPT2']",0.9999956487937446,0,0,7
509,Endometrial cancer WP4155,0.9394623121844597,0.6178201841830437,0.03858137271560622,"['TCF7L1', 'CDH1', 'LEF1', 'FGF2', 'ELK1', 'HRAS', 'EGFR', 'DDB2', 'MAPK3']",0.9999956487937446,0,0,9
510,miRNA regulation of DNA damage response WP1530,0.9409954092642039,0.6282292722970689,0.038207030948961974,"['CCND3', 'CDKN1B', 'RAD51', 'CHEK2', 'CDK2', 'PMAIP1', 'TNFRSF10B', 'CYCS', 'DDB2', 'RAD9A']",0.9999956487937446,0,0,10
511,Disruption of postsynaptic signaling by CNV WP4875,0.9410608448526054,0.5115530971715507,0.0310755624128483,"['ARC', 'HOMER1', 'YWHAG', 'MAPK3']",0.9999956487937446,0,0,4
512,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.9429032996918113,0.33733757007414295,0.01983259760674482,['NFKBIA'],0.9999956487937446,0,0,1
513,Interferon type I signaling pathways WP585,0.9450824061348626,0.5767024069329791,0.03257397030424323,"['STAT5A', 'ZAP70', 'SOCS3', 'RPS6KA5', 'PTPRC', 'PTPN6', 'VAV1']",0.9999956487937446,0,0,7
514,7q11.23 copy number variation syndrome WP4932,0.9452929097075384,0.6695770242166956,0.03767069943777339,"['PKLR', 'FZD9', 'HMGA1', 'ATP5MC3', 'VPS37D', 'ACACB', 'ATP5MC1', 'CLDN5', 'ATP5F1B', 'BCL7B', 'BTK', 'EIF4H', 'WNT2', 'GAPDH', 'MAPK3']",0.9999956487937446,0,0,15
515,Lipid Metabolism Pathway WP3965,0.9462482453123395,0.4636408871197043,0.025616311361901914,"['ACLY', 'PRKAR1A', 'ACSBG1']",0.9999956487937446,0,0,3
516,Non-small cell lung cancer WP4255,0.9531395514889665,0.6075381813086731,0.02915815841331656,"['STAT5A', 'CDKN2A', 'PLCG2', 'TGFA', 'CYCS', 'HRAS', 'FHIT', 'EGFR', 'DDB2', 'MAPK3']",0.9999956487937446,0,0,10
517,Resistin as a regulator of inflammation WP4481,0.9548696988378707,0.44506113164628947,0.020553096107112652,"['NFKBIA', 'PLCG2', 'MAPK3']",0.9999956487937446,0,0,3
518,Purine metabolism and related disorders WP4224,0.9556198177145859,0.3904730558630801,0.017725573274277668,"['PRPS1', 'XDH']",0.9999956487937446,0,0,2
519,DNA damage response (only ATM dependent) WP710,0.9568501652708647,0.658498224251649,0.029045347129546106,"['WNT10A', 'JUN', 'TCF7L1', 'CDKN1B', 'MLKL', 'BIK', 'CDKN2A', 'LEF1', 'WNT16', 'PIK3R5', 'FRAT1', 'CCND3', 'BCL6', 'PMAIP1', 'WNT2', 'HRAS']",0.9999956487937446,0,0,16
520,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9571422253298206,0.47847627435869206,0.02095883154053838,"['MAP1LC3A', 'MSTN', 'IGFBP5', 'TNFSF9']",0.9999956487937446,0,0,4
521,Cell cycle WP179,0.9601543015783706,0.6665962307252998,0.027104653734880572,"['CDKN2D', 'CDKN1B', 'YWHAB', 'CDKN2A', 'TTK', 'CDC14A', 'CCNA2', 'CCND3', 'PTTG1', 'TFDP2', 'PTTG2', 'CHEK2', 'CDK2', 'MCM4', 'MCM5', 'YWHAG', 'SKP1', 'YWHAH']",0.9999956487937446,0,0,18
522,Eukaryotic Transcription Initiation WP405,0.9605306103133848,0.5010187997385721,0.020175740551228026,"['TAF13', 'POLR2E', 'POLR2I', 'POLR3K', 'POLR2K']",0.9999956487937446,0,0,5
523,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9605306103133848,0.5010187997385721,0.020175740551228026,"['NFKBIA', 'NEFL', 'CYCS', 'CALM1', 'CALM2']",0.9999956487937446,0,0,5
524,G Protein Signaling Pathways WP35,0.9611171652286398,0.6254503979054877,0.024804710642845985,"['GNAZ', 'PRKCH', 'ADCY4', 'AKAP5', 'GNG12', 'GNG11', 'GNA14', 'GNG10', 'GNG3', 'PRKAR1A', 'CALM1', 'HRAS', 'CALM2']",0.9999956487937446,0,0,13
525,IL-1 signaling pathway WP195,0.9631798893778899,0.5405339690672739,0.02027817704559673,"['NFKBIA', 'JUN', 'IL1R1', 'TOLLIP', 'PELI2', 'IRAK3', 'MAPK3']",0.9999956487937446,0,0,7
526,1q21.1 copy number variation syndrome WP4905,0.963631301582714,0.3709209778283115,0.013741333192342723,"['GJA1', 'TJP2']",0.9999956487937446,0,0,2
527,Androgen receptor signaling pathway WP138,0.9642851424962896,0.6089876759188392,0.02214780821185145,"['KAT2B', 'JUN', 'TGFB1I1', 'LIMK2', 'RNF6', 'STUB1', 'FKBP4', 'ETV5', 'FOXO1', 'EGFR', 'RAN', 'RAD9A']",0.9999956487937446,0,0,12
528,Omega-3/Omega-6 FA synthesis WP4723,0.9645768056809733,0.2853957636566332,0.01029303143232832,['PLA2G5'],0.9999956487937446,0,0,1
529,Riboflavin and CoQ disorders WP5037,0.9645768056809733,0.2853957636566332,0.01029303143232832,['RFK'],0.9999956487937446,0,0,1
530,MAPK Signaling Pathway WP382,0.9689941921353881,0.7358415069561292,0.023176550330721614,"['HSPB1', 'ELK1', 'FGF2', 'EGFR', 'RELB', 'RPS6KA5', 'FGF8', 'STMN1', 'MKNK2', 'MAP3K8', 'CD14', 'CACNG1', 'HRAS', 'CACNG4', 'CACNG5', 'MAPK3', 'DUSP4', 'PDGFRB', 'NTRK1', 'HSPA8', 'JUN', 'DUSP2', 'DUSP3', 'PLA2G4D', 'IL1R1', 'PLA2G4E', 'IL1R2', 'NFATC1', 'GNG12', 'DUSP6', 'DUSP7', 'TGFBR2', 'FGF17', 'NR4A1', 'DDIT3', 'FGFR4', 'HSPA1B', 'HSPA1A', 'FGF10']",0.9999956487937446,0,0,39
531,Wnt Signaling Pathway WP363,0.9690402785517414,0.5054457494696538,0.01589581433532474,"['GSK3A', 'FRAT1', 'GJA1', 'LEF1', 'LRP5', 'NFATC2']",0.9999956487937446,0,0,6
532,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9692412333381119,0.6730079525962888,0.021025944359762357,"['NSF', 'SHC4', 'STAT5A', 'VAV3', 'NTRK1', 'NGFR', 'EGR1', 'JUN', 'EGR2', 'RAB3A', 'SHC3', 'NCF1', 'ELK1', 'ACACB', 'NFKBIA', 'RPS6KA5', 'IGF2BP1', 'SPP1', 'ALPL', 'HRAS', 'MAPK3', 'CDK5R1']",0.9999956487937446,0,0,22
533,Estrogen signaling pathway WP712,0.9702420261645927,0.35323100246352096,0.010671012186848454,"['JUN', 'ELK1']",0.9999956487937446,0,0,2
534,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.97093205852499,0.47525258051573843,0.014019373104942359,"['ABCA1', 'CYP27A1', 'HMGCS1', 'DHCR24', 'HMGCR']",0.9999956487937446,0,0,5
535,Fatty acid transporters WP5061,0.9720991340253359,0.26499005399261155,0.007498553398794466,['ACSBG1'],0.9999956487937446,0,0,1
536,GPR40 Pathway WP3958,0.9720991340253359,0.26499005399261155,0.007498553398794466,['PLCG2'],0.9999956487937446,0,0,1
537,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9751199614696965,0.4633357041251778,0.011673640273459756,"['ADCY10', 'ADCY4', 'BANF1', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,5
538,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9751199614696965,0.4633357041251778,0.011673640273459756,"['EIF4A2', 'RPS6KA5', 'PIM1', 'PIM2', 'MAPK3']",0.9999956487937446,0,0,5
539,Male infertility WP4673,0.9760675737333739,0.6103368813782508,0.014784470778170517,"['CCDC36', 'MMP2', 'PON2', 'HMGA1', 'TEX15', 'THBS1', 'SOD3', 'ETV5', 'CYP26B1', 'FOLH1', 'TCN2', 'MSH4', 'EPSTI1', 'HLA-DRA', 'SOX5']",0.9999956487937446,0,0,15
540,Fatty acid beta-oxidation WP143,0.9779847165750445,0.38355573421705413,0.008538424831058678,"['CPT1A', 'TPI1', 'LPL']",0.9999956487937446,0,0,3
541,Proteasome Degradation WP183,0.9788977895242819,0.49880115614530646,0.01063845342420982,"['PSMD8', 'PSMB6', 'UBA7', 'H2AFZ', 'NEDD4', 'HLA-E', 'PSMB9']",0.9999956487937446,0,0,7
542,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.980122453225001,0.47307426827643834,0.00949827297030844,"['DDX3Y', 'IFIH1', 'NFKBIA', 'RNF125', 'CASP10', 'IRF7']",0.9999956487937446,0,0,6
543,Glycosylation and related congenital defects WP4521,0.9801593963281985,0.32246582791605904,0.0064622381603552615,"['DOLK', 'MGAT2']",0.9999956487937446,0,0,2
544,Signal Transduction of S1P Receptor WP26,0.9801593963281985,0.32246582791605904,0.0064622381603552615,"['S1PR1', 'MAPK3']",0.9999956487937446,0,0,2
545,Rett syndrome causing genes WP4312,0.9845496126554772,0.43091071487644317,0.006709705748784537,"['CECR2', 'KCNJ10', 'TBL1X', 'HAP1', 'GABRD']",0.9999956487937446,0,0,5
546,EGF/EGFR signaling pathway WP437,0.9860673083727696,0.6348832047938745,0.008907832062037088,"['STAT5A', 'VAV3', 'JUN', 'LIMK2', 'GAB1', 'FOXO4', 'ELK1', 'FOXO1', 'EPN1', 'VAV1', 'EGFR', 'EPS8', 'GJA1', 'PLSCR1', 'RPS6KA5', 'INPP5D', 'NEDD4', 'STMN1', 'FOSB', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.9999956487937446,0,0,23
547,AMP-activated protein kinase (AMPK) signaling WP1403,0.9863210752358612,0.4714851331418368,0.006493926587035653,"['GYS2', 'CCNA2', 'CPT1A', 'LEP', 'LEPR', 'HMGCR', 'ACACB']",0.9999956487937446,0,0,7
548,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9863673538630142,0.21817695535162063,0.0029947893799586725,['MAP1LC3A'],0.9999956487937446,0,0,1
549,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9867311727728807,0.39012633974013533,0.005211169018296584,"['FA2H', 'MAP1LC3A', 'ATG101', 'CP']",0.9999956487937446,0,0,4
550,Intraflagellar transport proteins binding to dynein WP4532,0.9868363464846486,0.296623081296191,0.003930570938556061,"['DYNLT3', 'DYNLL2']",0.9999956487937446,0,0,2
551,Nanoparticle-mediated activation of receptor signaling WP2643,0.9868363464846486,0.296623081296191,0.003930570938556061,"['HRAS', 'EGFR']",0.9999956487937446,0,0,2
552,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9888381903102634,0.41169590643274856,0.004621109577266198,"['NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFAF4', 'TMEM70']",0.9999956487937446,0,0,5
553,Integrated Cancer Pathway WP1971,0.9888473797374578,0.3800939295819842,0.004262858715978191,"['BARD1', 'CDKN1B', 'CHEK2', 'CDK2']",0.9999956487937446,0,0,4
554,Interleukin-11 Signaling Pathway WP2332,0.9888473797374578,0.3800939295819842,0.004262858715978191,"['SOCS3', 'ITGA2', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,4
555,Integrated breast cancer pathway WP1984,0.9890494768639194,0.611607815956415,0.006734365618498797,"['BARD1', 'JUN', 'GSK3A', 'ODC1', 'HMGCR', 'SMAD6', 'JAKMIP1', 'TFPI', 'MYT1', 'CYP19A1', 'FOXO1', 'EGFR', 'FOSL2', 'TGFBR2', 'VEGFA', 'RAD51', 'CDH1', 'CHEK2', 'CDK2', 'RHO', 'FAU']",0.9999956487937446,0,0,21
556,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9892627140679167,0.20604022607432668,0.0022242756477943697,['CASP7'],0.9999956487937446,0,0,1
557,Autophagy WP4923,0.9892952738714058,0.2851926356758648,0.0030693668929342344,"['ATG101', 'ATG9A']",0.9999956487937446,0,0,2
558,Glycerophospholipid Biosynthetic Pathway WP2533,0.9892952738714058,0.2851926356758648,0.0030693668929342344,"['GPD1', 'CDIPT']",0.9999956487937446,0,0,2
559,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9898257732618656,0.4548718793853407,0.004651673560334139,"['ACLY', 'GSK3A', 'RBP4', 'HMGCS1', 'LPL', 'HMGCR', 'ACSS1']",0.9999956487937446,0,0,7
560,Thermogenesis WP4321,0.9903169558532505,0.5406202042143642,0.005260358748776723,"['KLB', 'CPT1A', 'UCP1', 'ADCY4', 'ACTB', 'ACTG1', 'ADCY10', 'CREB3', 'CREB3L1', 'CREB3L2', 'PRDM16', 'DPF3', 'HRAS']",0.9999956487937446,0,0,13
561,Cardiac Hypertrophic Response WP2795,0.9905327616139109,0.4027150720514565,0.0038307617043178933,"['NFATC2', 'CALM1', 'FGF2', 'CALM2', 'MAPK3']",0.9999956487937446,0,0,5
562,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9918133126336189,0.46287727790432803,0.0038050281904249816,"['TCF7L1', 'JUN', 'LEF1', 'PMAIP1', 'CYCS', 'TGFBR2', 'DDB2', 'MAPK3']",0.9999956487937446,0,0,8
563,DNA IR-damage and cellular response via ATR WP4016,0.9924339453718476,0.4760182284249502,0.0036152739121931444,"['BARD1', 'SEM1', 'FEN1', 'RAD51', 'BCL6', 'CHEK2', 'CDK2', 'FOXM1', 'RAD9A']",0.9999956487937446,0,0,9
564,Glycerolipids and Glycerophospholipids WP4722,0.9933392829721847,0.18540778630292698,0.001239079976184134,['CDIPT'],0.9999956487937446,0,0,1
565,Energy Metabolism WP1541,0.9934302910049104,0.3528631020098597,0.0023258563882602055,"['UCP2', 'PPARA', 'MEF2D', 'FOXO1']",0.9999956487937446,0,0,4
566,Histone Modifications WP2369,0.9934302910049104,0.3528631020098597,0.0023258563882602055,"['SET', 'SUV39H1', 'SMYD1', 'HIST1H3E']",0.9999956487937446,0,0,4
567,Immune response to tuberculosis WP4197,0.9947538957697587,0.17656531211518423,0.0009287182427430914,['OAS1'],0.9999956487937446,0,0,1
568,Nanoparticle triggered autophagic cell death WP2509,0.9947538957697587,0.17656531211518423,0.0009287182427430914,['MAP1LC3A'],0.9999956487937446,0,0,1
569,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9951626480865355,0.3703840682788051,0.0017960255960749218,"['YAP1', 'RAD51', 'CDKN2A', 'CHEK2', 'RAD9A']",0.9999956487937446,0,0,5
570,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9954115035629644,0.3367721584445134,0.0015488339824410511,"['ARC', 'HOMER1', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,4
571,Splicing factor NOVA regulated synaptic proteins WP4148,0.9959765880673359,0.2925115603908834,0.0011792684378974846,"['APLP2', 'STXBP2', 'NCDN']",0.9999956487937446,0,0,3
572,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9960968047128279,0.4291703806411145,0.0016784135300479128,"['FZD2', 'CISH', 'LRP5', 'CALM1', 'FGF2', 'CALM2', 'AGT', 'MAPK3']",0.9999956487937446,0,0,8
573,MET in type 1 papillary renal cell carcinoma WP4205,0.9965665735348577,0.3560838166101324,0.001224691248597899,"['JUN', 'HGF', 'GAB1', 'HRAS', 'MAPK3']",0.9999956487937446,0,0,5
574,MTHFR deficiency WP4288,0.9967454712457268,0.16118709613650123,0.0005254435392936366,['CYCS'],0.9999956487937446,0,0,1
575,Pancreatic adenocarcinoma pathway WP4263,0.996811945572777,0.43823547047624756,0.0013993503214184645,"['RAD51', 'CDKN2A', 'TGFA', 'DUSP6', 'EGFR', 'TGFBR2', 'DDB2', 'MAPK3', 'VEGFA']",0.9999956487937446,0,0,9
576,ATM Signaling Network in Development and Disease  WP3878,0.9972757384554055,0.27784333238555586,0.0007579508033600917,"['CHEK2', 'HSPB1', 'CDK5R1']",0.9999956487937446,0,0,3
577,Insulin Signaling WP481,0.997872062706561,0.5393952033368091,0.0011490221266371155,"['EGR1', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'PRKCH', 'SHC3', 'STXBP2', 'GAB1', 'ELK1', 'FOXO1', 'GYS2', 'SOCS3', 'RPS6KA5', 'RHOJ', 'MAP3K8', 'SGK1', 'HRAS', 'ARF6', 'MAPK3']",0.9999956487937446,0,0,20
578,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9990126245395372,0.1323529411764706,0.00013074660485974272,['ACTA2'],0.9999956487937446,0,0,1
579,Ciliopathies WP4803,0.999158226207741,0.5240008115236356,0.00044127590357614504,"['EVC2', 'DNAH11', 'RSPH4A', 'DNAAF3', 'CCDC114', 'DCDC2', 'CFAP410', 'GLI3', 'GLI2', 'RP1L1', 'TMEM17', 'EVC', 'SMO', 'ZIC2', 'MAK', 'SUFU', 'BBS9', 'NEK2', 'CCDC65', 'ZNF423', 'CCDC151', 'CCNO']",0.9999956487937446,0,0,22
580,Joubert Syndrome WP4656,0.9993527523145921,0.32645050051893265,0.0002113627402645739,"['TMEM17', 'CETN2', 'SUFU', 'BBS9', 'PDE6A', 'ZNF423']",0.9999956487937446,0,0,6
581,Fragile X Syndrome  WP4549,0.9994553315663196,0.42234891676168757,0.00023010279351340954,"['GABRA1', 'CPT1A', 'ARC', 'DUSP3', 'HOMER1', 'PRKAR1A', 'CDKN2A', 'GAD1', 'GAB1', 'AKAP5', 'GABRD', 'AP2M1']",0.9999956487937446,0,0,12
582,Ciliary landscape WP4352,0.9994559785657003,0.5412922117526979,0.00029455469471334613,"['YAP1', 'DOCK5', 'VPS4A', 'USH1C', 'COPS7A', 'PSMD8', 'EXOSC4', 'ARHGDIA', 'CDH23', 'NEFL', 'BBS9', 'STOM', 'NEFM', 'TFAP2C', 'WHRN', 'DYNLT3', 'DYNLL2', 'LSM4', 'GID8', 'CD2BP2', 'MCM4', 'MCM5', 'EFHC2', 'VIM', 'CALM1', 'COPS8', 'CALM2']",0.9999956487937446,0,0,27
583,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9999309761888165,0.3594196465725303,2.4809370049133686e-05,"['SLCO1C1', 'GSK3A', 'RPS6KA5', 'SHC3', 'TRIP10', 'LPL', 'MAP3K8', 'CYP3A4', 'HRAS', 'FOXO1', 'MAPK3']",0.9999956487937446,0,0,11
584,DNA Repair Pathways Full Network WP4946,0.9999501626791341,0.3387438249823571,1.6882505389915707e-05,"['FEN1', 'NEIL2', 'RAD51', 'CETN2', 'POLD1', 'RPA3', 'APEX1', 'POLE3', 'POLE', 'DDB2']",0.9999956487937446,0,0,10
585,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999928453710804,0.22834142076759237,1.6337039768571113e-06,"['EVC2', 'TMEM17', 'EVC', 'CDK20', 'BBS9', 'TULP3']",0.9999956487937446,0,0,6
586,mRNA Processing WP411,0.9999956487937446,0.1207314571327328,5.253286144087427e-07,"['NCBP2', 'CD2BP2', 'SNRPE', 'SNU13']",0.9999956487937446,0,0,4
